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ABSTRACT 
Introduction and aim: Patients with neuropathic pain suffer from spontaneous ongoing pain and from 
abnormal stimulus-evoked pain, e.g., allodynia. Dynamic mechanical allodynia (DMA) is evoked by a 
normally innocuous light moving mechanical stimulus on the skin and static mechanical allodynia (SMA) 
by a sustained, normally innocuous pressure against the skin. Some patients report variable intensity of 
DMA which at times is only unpleasant, i.e., dynamic mechanical dysesthesia (DMD). The aim was to 
probe for common denominators of sensory disturbances linked to mechanisms underlying development 
of or protection against pain after a traumatic peripheral nerve injury (Study I). Also, we aimed at 
examining if short or longer lasting non-painful von Frey filament stimulation of the neuropathic skin 
could be used to assess perception thresholds to DMA and SMA (Study II). Further, we investigated if 
DMA is the hyperbole of DMD both mediated by A-beta fibres in the periphery (Study III). Finally, we 
explored the modulatory effect of spinal cord stimulation (SCS) on somatosensory functions within the 
painful area (Study IV).  
Methods: Using methods of quantitative sensory testing a detailed analysis of somatosensory functions 
was performed in patients with and without pain after a traumatic peripheral nerve injury (Study I) and in 
patients reporting a sustained pain relieving effect of at least 30 % following SCS (Study IV). A 
compression/ischemia-induced (differential) nerve block in conjunction with repeated quantitative 
sensory testing of A-delta and C-fibre function was used to assess which nerve fibre population that 
contributes to pain at perception threshold level using 1 s (vF1) and 10 s (vF10) von Frey filament 
stimulation of the skin (Study II). The same approach was used to study which part of the peripheral fibre 
spectrum that contributes to DMA and DMD (Study III). 
Results: Pain patients reported allodynia to cold and pressure in conjunction with an increase in the 
perception threshold to non-painful warmth on the injured side compared to the uninjured side. Pain-free 
patients reported hypoesthesia to light touch, cold and warmth on the injured side. No significant 
difference could be demonstrated comparing side-to-side differences between patients with and without 
pain. During the nerve block elevation of vF1 and vF10 occurred simultaneously and significantly prior 
to an increase in the perception level to cold or warmth. During the nerve block there was a transition of 
DMA to DMD in all patients with peripheral neuropathic pain and in 3/7 patients with central post stroke 
pain. Remaining patients lost DMA without transition. The transition/loss of DMA occurred early and 
concurrently in time in all patients paralleled by a continuous impairment of mainly A-beta fibre function. 
Following SCS decreased perception threshold to light touch and increased perception threshold to 
pressure pain were found in the neuropathic area when comparing with pre-stimulation values. Compared 
to the contralateral side these perception thresholds changed towards normalisation also including a 
significant normalisation of the perception threshold to non painful cold. SCS did not alter sensitivity to 
noxious temperature stimulation. 
Conclusions: Increased pain sensitivity to cold and pressure was found on the injured side in pain 
patients, pointing to hyperexcitability in the pain system, not verified by a more challenging analysis of 
side-to side differences between patients with and without pain. A-beta fibres are the peripheral mediators 
of both vF1 and vF10 although different receptor organs may be involved, i.e., rapidly (RA) and slowly 
(SA-I) adapting mechanoreceptors, respectively. We suggest DMA to be the hyperbole of DMD, the 
difference being the number of mechanoreceptive fibres having access to the nociceptive system. Sensory 
alterations following SCS indicate a possible link to the release of a functional block on somatosensory 
function induced by activity in the nociceptive system. No significant correlation could be demonstrated 
between the degree of threshold alterations versus the degree of SCS-induced pain relief.  
 
Keywords: Peripheral neuropathic pain; Central post stroke pain; Dynamic mechanical allodynia; Static 
mechanical allodynia; Dysesthesia; Quantitative sensory testing; Spinal cord stimulation. 
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1 INTRODUCTION 
According to the IASP (International Association for the Study of Pain) neuropathic 
pain is defined as ‘pain initiated or caused by a primary lesion or dysfunction in the 
nervous system’ (Merskey and Bogduk, 1994). A new definition has recently been 
proposed as follows: ‘pain arising as a direct consequence of a lesion or disease 
affecting the somatosensory system’ (Treede et al., 2008). This redefinition makes it 
possible to more accurately differentiate neuropathic pain conditions from nociceptive 
pain conditions with secondary neuroplastic changes and from pain induced by 
spasticity or other muscular alterations due to injuries of motor nerves/central 
pathways.  
 
The prevalence of neuropathic pain is not extensively studied but has been 
approximated to 1-8 % (Bowsher, 1991; Torrance et al., 2006). A rough estimation is 
that about 5 % of patients with traumatic peripheral nerve injury develop neuropathic 
pain (Sunderland, 1993). Central neuropathic pain has been estimated to occur in up to 
8 % of patients after a stroke during a 1-year follow-up (Andersen et al., 1995). Patients 
suffering from neuropathic pain have reduced health-related quality of life compared to 
the general population (Meyer-Rosberg et al., 2001; Doth et al., 2010). Neuropathic 
pain is also associated with low levels of health utility and the severity of the 
neuropathic pain condition is a predictor of the negative health impact (Doth et al., 
2010).   
 
The diagnosis of neuropathic pain is based on a history of injury to a nervous structure 
or central pathway, a distribution of pain corresponding to the peripheral innervation 
territory of the injured nervous structure or to the topographic representation of the 
body part in the lesioned CNS area in conjunction with findings of sensory 
abnormalities within the area of pain at bedside examination (Hansson, 2002). A 
grading system of possible, probable and definite neuropathic pain has been proposed 
to determine the level of certainty with which the neuropathic pain diagnosis can be 
made in an individual patient (Treede et al., 2008).  
 
1.1 TRAUMATIC PERIPHERAL NERVE INJURY  
Why traumatic injuries to the peripheral nervous system result in neuropathic pain in 
only a fraction of inflicted patients (Sunderland, 1993) is still unknown but indicate 
inborn pain protective mechanisms to be the normal condition in most individuals. 
Besides increased peripheral activity due to, e.g., ectopic impulse discharge and 
ephaptic transmission, increase in spinal cord excitability has in animal models been 
suggested to be a built in compensation for some of the deficits in the afferent 
nociceptive drive after nerve injury (Chapman et al., 1998; Suzuki and Dickenson, 
2000; Suzuki et al., 2000). Also, disinhibition of spinal neurones due to loss of 
peripheral input may come into play (Castro-Lopes et al., 1993; Moore et al., 2002). A 
mechanism-based classification of neuropathic pain is not available and it is currently 
not possible to translate clinical symptoms and signs into identified distinct 
pathophysiological mechanisms thereby linking therapy to pain mechanisms (Hansson, 
2003; Baron et al., 2010). To eventually accomplish this there is a need for a 
continuous collaboration among clinicians and basic scientist. 
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Patients with neuropathic pain, spontaneous and/or abnormal stimulus-evoked pain, of 
peripheral traumatic origin may present with seemingly random combinations of both 
qualitative and quantitative sensory abnormalities in the innervation territory of the 
injured nervous structure (Lindblom and Tegner, 1985; Hansson and Kinnman, 1996; 
Pertovaara, 1998). No pathognomonic somatosensory aberration patterns have so far 
been identified in such patients. Since a mechanism-based classification is not available 
searching for common denominators of sensory disturbances may provide links to 
mechanisms underlying pain development and maintenance after traumatic peripheral 
nerve injury. Meticulous somatosensory testing with the aim of phenotyping subgroups 
of patients with and without pain based on somatosensory findings and symptoms 
could be a first step towards such a link. Sensory disturbances with bearing on 
development of spontaneous pain after nerve injury could reasonably be expected to be 
related to alterations in activity in nociceptive channels. Previous attempts comparing 
sensory findings from patients with traumatic peripheral nerve injuries with and 
without pain are scarce (Gottrup et al., 2000; Jaaskelainen et al., 2005; Aasvang et al., 
2008). The findings of allodynia to mechanical pressure and abnormal temporal 
summation of pinprick pain on the affected side compared to the normal side were 
interpreted by the authors as signs of peripheral and/or central hyperexcitability 
contributing to spontaneous pain while hypoesthesia to non-nociceptive stimuli could 
not define patients with and without pain (Gottrup et al., 2000; Jaaskelainen et al., 
2005; Aasvang et al., 2008).  
 
1.2 CENTRAL POST STROKE PAIN 
Central post stroke pain (CPSP) is less studied than peripheral neuropathic pain 
conditions and is a challenge to the clinician when it comes to diagnosis and treatment. 
Patients with CPSP complain of continuous ongoing pain located in the area 
corresponding to the topographic representation of the body part in the lesioned CNS 
area and sometimes also from stimulus evoked pain, e.g., allodynia. Patients with CPSP 
all have a lesion that affects temperature- and pain sensibility, i.e., the spino-trigemino-
thalamo-cortical pathway (Leijon et al., 1989; Vestergaard et al., 1995) however all 
patients with a lesion to the spino-trigemino-thalamo-cortical do not develop CPSP. 
Only a minority of patients have a lesion affecting vibration and tactile sensibility 
(Boivie et al., 1989). Disinhibition following deafferentation, sensitization and 
plasticity changes, all hypothetical phenomena, have been suggested to underlie the 
development of CPSP (Craig, 2007).   
 
1.3 MECHANICAL ALLODYNIA AND DYSESTHESIA 
Patients with neuropathic pain usually present with spontaneous ongoing pain and 
sometimes with additional abnormal stimulus-evoked pain (e.g., allodynia) (Cruccu et 
al., 2004). Not infrequently also abnormal spontaneous and/or evoked non-painful 
sensory phenomena such as paresthesia and dysesthesia are reported. According to the 
IASP allodynia is defined as ‘pain due to a stimulus which does not normally provoke 
pain’ and dysesthesia is defined as ‘an unpleasant abnormal sensation, whether 
spontaneous or evoked’ (Merskey and Bogduk, 1994). Two types of mechanical 
allodynia have been distinguished in studies of neuropathic pain patients; dynamic 
mechanical allodynia (DMA) and static mechanical allodynia (SMA) (Koltzenburg et 
al., 1992; Ochoa and Yarnitsky, 1993). Clinically, DMA is evoked by a normally 
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innocuous light moving mechanical stimulus on the skin and SMA by a light sustained 
normally innocuous pressure against the skin.  
 
DMA is an oppressive symptom in subgroups of patients with neuropathic pain 
interfering extensively with activity of daily living (Smith and Sang, 2002; Hensing et 
al., 2007). The prevalence of DMA has been reported en passant in limited groups of 
patients in studies aiming at other issues (Leijon et al., 1989; Andersen et al., 1995; 
Gottrup et al., 2000; Martin et al., 2003; Otto et al., 2003; Greenspan et al., 2004) and 
seems to be present in a minority of patients. In a recent large study of patients with 
neuropathic pain the prevalence of DMA was reported to be 20 % across diagnostic 
entities, most frequently found in patients with post herpetic neuralgia (49%) (Maier et 
al., 2010). The high prevalence in this patient group could possibly be explained by the 
presence of peripheral sensitization/neurogenic inflammation in subgroups of patients. 
 
Clinical empiricism supports the notion of similar perceptual characteristics reported by 
patients with DMA of peripheral and central neuropathic origin despite completely 
different lesion levels. It has been suggested that DMA usually has a distribution within 
the entire or part of the proper innervation territory of the lesioned peripheral nervous 
structure or central pathway and in most patients is a constant finding (Hansson, 2003). 
However, in subgroups of patients it is a clinical observation that the phenomenon 
varies in intensity and at times only an unpleasant, i.e., dysesthetic sensation, or even 
just a sensation of touch can be evoked by lightly touching the skin. Dynamic 
mechanical dysesthesia (DMD) and DMA may also coexist in different areas of the 
neuropathy distribution and in the clinical setting most patients are usually able to 
differentiate between a painful and a dysesthetic sensation during examination. 
 
In peripheral neuropathic pain conditions there are several lines of evidence in the 
literature indicating different peripheral nerve fibre correlate to DMA and SMA, 
respectively. With the exception of, e.g., subgroups of patients with post herpetic 
neuralgia and nociceptor sensitisation (Fields et al., 1998) DMA is claimed to be 
mediated by myelinated fibres (Koltzenburg et al., 1992; Ochoa and Yarnitsky, 1993; 
Kilo et al., 1994; Field et al., 1999) and SMA by C-fibres (Koltzenburg et al., 1992; 
Ochoa and Yarnitsky, 1993; Kilo et al., 1994; Field et al., 1999) but also A-delta fibres 
have been implicated in the static subtype (Field et al., 1999; Ziegler et al., 1999). 
Other afferents than low threshold A-beta mechanoreceptive fibres may, however also 
be suggested as possible candidates mediating DMA in patients with PNeP. 
Experimental animal studies have identified nociceptive A-beta fibres (Cain et al., 
2001; Djouhri and Lawson, 2004) and in humans A-delta low-threshold 
mechanoreceptors have been reported (Adriaensen et al., 1983). In primates C-fibre 
nociceptors with low mechanical threshold have been documented (Slugg et al., 2000) 
and in human skin low-threshold mechanoreceptive C-fibres involved in touch 
sensation (Vallbo et al., 1993; McGlone et al., 2007). Peripheral sensitization (Fields et 
al., 1998), ephaptic transmission between A-beta fibres and nociceptive fibres (Amir 
and Devor, 1992), alterations in spinal cord excitability (Laird and Bennett, 1992), 
central sensitization (Fields et al., 1998), descending facilitation of dorsal horn neurons 
(Suzuki et al., 2002) and sprouting of mechanoreceptive fibers from deeper- to more 
superficial layers of the dorsal horn where synaptic couplings to nociceptive neurons 
may take place (Woolf et al., 1992; Woolf et al., 1995; Bao et al., 2002) have also been 
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suggested as possible pathophysiological mechanisms underlying DMA. The 
pathophysiological basis for DMA in patients with central post-stroke pain (CPSP) is 
unknown. The neurophysiological basis for DMD has, to our knowledge, never been 
addressed. 
 
Non-quantitative brushing stimuli are usually employed to induce DMA (Leijon et al., 
1989; Andersen et al., 1995; Gottrup et al., 2000; Martin et al., 2003; Otto et al., 2003; 
Greenspan et al., 2004) and moving a brush across the non-inflamed skin surface is 
likely to result in dynamic activation and deactivation of both rapidly adapting (RA) 
and slowly adapting (SA) mechanoreceptors (Johnson, 2001; Lundstrom, 2002; 
Samuelsson et al., 2005). A brief vertical, about 1 second (s), stimulation of the skin 
with a thin von Frey filament causes a dynamic deformation of the skin surface and an 
“on-off” activation of A-beta mechanoreceptors (Johansson et al., 1980). Hence, a 
vertical deformation of the skin induced by stimulation with a von Frey filament 
activates the same peripheral substrate as a horizontally moving brush although the 
spatial activation pattern is lacking using the former.  
 
Various types of mechanical stimuli have been used to study hypersensitivity to static 
mechanical stimuli, some activating non-nociceptive- and some nociceptive fibres; von 
Frey filament prodding (Attal et al., 1999; Wallace et al., 2002), gentle manual pressure 
or pinching (Ochoa and Yarnitsky, 1993), pressure-algometry (Koltzenburg et al., 
1992) and tonic pressure (Kilo et al., 1994). Mechanical stimulation by prodding the 
skin with a von Frey filament is likely to result in activation of mechanoreceptors and 
also a possibility of activating nociceptors, sensitized or not, the latter not necessarily 
resulting in pain perception (Adriaensen et al., 1983; Schmidt et al., 1995; Andrew and 
Greenspan, 1999; Slugg et al., 2000). In addition, the duration of the “static” stimulus 
varied and no gold standard has been defined. Under normal conditions a light 
sustained non-painful pressure applied to the skin results in activation of A-beta 
mechanoreceptors (Guyton and Hall, 2000). In patients with peripheral neuropathic 
pain and SMA, based on the aforementioned published data, a sustained, about 10 s 
indentation of the skin with a von Frey filament would hypothetically result in 
activation of epidermal C- and A-delta nociceptors (Garell et al., 1996; Treede et al., 
2002).  
 
1.4 SPINAL CORD STIMULATION 
The treatment options for neuropathic pain conditions are limited and often provide 
only partial pain relief. Besides pharmacotherapy (Attal et al., 2010) one of the 
treatment options in peripheral neuropathic pain conditions is spinal cord stimulation 
(SCS) which evolved as a direct consequence from the gate-control theory (Melzack 
and Wall, 1965). However, the pathophysiological mechanisms causing pain relief in 
peripheral neuropathic pain conditions are to a large extent unknown despite four 
decades of experience using SCS. In contradiction to the original theory the method is 
not efficacious in acute nociceptive pain conditions but has been proven to be so in 
patients with painful radiculopathy in failed back surgery syndrome (FBSS) (Cruccu et 
al., 2007; Kumar et al., 2007). The method is suggested to antidromically activate the 
dorsal columns mediating inhibitory activity into the dorsal horn (Meyerson and 
Linderoth, 2006) and/or via supraspinal loops including descending inhibition thus 
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reducing spinal hyperexcitability (Saade et al., 2006; Song et al., 2009). In experimental 
animal models of neuropathy, not necessarily painful, SCS has been demonstrated to 
inhibit hyperexcitability in the dorsal horn by inducing release of numerous 
neurotransmitters, e.g. GABA (Cui et al., 1997a), adenosine (Cui et al., 1997b; Cui et 
al., 1998), serotonin and noradrenalin (Linderoth et al., 1992; Linderoth and Foreman, 
2006) and acetylcholine (Schechtmann et al., 2004; Schechtmann et al., 2008) possibly 
restoring the balance between excitation/inhibition in the dorsal horn.  
 
Peripheral neuropathic pain patients present with seemingly random profiles of sensory 
abnormalities in the innervation territory of the injured nervous structure (Hansson and 
Kinnman, 1996) reflecting assessed loss of and (over-) compensated function, i.e., 
hypoesthesia and allodynia/hyperalgesia. Loss may result from deafferentation and 
both loss and compensated function has been demonstrated to result from activity in the 
nociceptive system affecting somatosensory function in nociceptive and non-
nociceptive channels (Leffler et al., 2000; Geber et al., 2008) which originally was 
suggested by others (Loh and Nathan, 1978; Lindblom and Verrillo, 1979). The latter, a 
functional block might explain improved sensitivity reported after pain relief in patients 
with neuropathy (Lindblom and Verrillo, 1979; Marchettini et al., 1992). Only few 
previous studies on very limited groups of patients have investigated the correlation 
between the modulatory effect of SCS on somatosensory function within the painful 
area and the relief of spontaneous pain in patients with painful neuropathy (Lindblom 
and Meyerson, 1975; Lindblom and Meyerson, 1976; Marchand et al., 1991; Eisenberg 
et al., 2006). The results are inconsistent possibly due to presence of nociceptive pain 
with referred pain components in part of the studied patient groups influencing 
somatosensory perception (Leffler et al., 2000).  
 
In this thesis, using methods of quantitative sensory testing a detailed analysis of 
somatosensory functions related to spontaneous ongoing pain, mechanical allodynia 
and pain relief was performed in patients with neuropathic pain. The purpose was to 
probe for common denominators of sensory disturbances linked to mechanisms 
underlying development of or protection against pain following a traumatic peripheral 
nerve injury. In addition, the aim was to examine if short or longer lasting non-painful 
von Frey filament stimulation of the neuropathic skin could be used to assess 
perception thresholds to dynamic mechanical and static mechanical allodynia. This 
could be used in intervention studies aimed at modifying such stimulus-evoked 
phenomena bearing in mind that suprathreshold stimuli is the every day problem in 
patients suffering from mechanical allodynia. Further, we aimed at examining if 
dynamic mechanical allodynia in patients with neuropathic pain could be the hyperbole 
of dynamic mechanical dysesthesia both mediated by A-beta fibres in the periphery. 
Finally, the thesis work probed the modulatory effect of spinal cord stimulation on 
somatosensory functions within the painful area because such an approach may 
disclose details about the link between sensory aberrations and spontaneous ongoing 
pain. 
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2 AIMS OF THE THESIS 
 
2.1 SPECIFIC AIMS 
 
2.1.1 Study I 
To examine the function of somatosensory systems in patients with traumatic 
peripheral nerve injury with and without pain probing for common denominators of 
sensory disturbances that may provide possible links to mechanisms underlying 
development of or protection against pain. Further, we aimed at extending the results of 
others by challenging the pain system using magnitude estimation of suprathreshold 
heat pain stimuli in patients with possibly less confounding trauma-related factors than 
in previous studies.  
 
2.1.2 Study II 
To examine if short (1 s) or longer (10 s) lasting usually non-painful von Frey filament 
stimulation of the neuropathic skin in patients with painful traumatic peripheral nerve 
injury could be used to assess perception thresholds to dynamic mechanical allodynia 
and static mechanical allodynia. Techniques to quantify the different allodynias at 
perception threshold level are in demand as adjuncts to suprathreshold stimuli in 
intervention studies aimed at modifying these stimulus-evoked phenomena.  
 
2.1.3 Study III 
To examine if dynamic mechanical allodynia in patients with peripheral neuropathic 
pain or central post stroke pain could be the hyperbole of dynamic mechanical 
dysesthesia both mediated by A-beta fibres in the periphery. We hypothesised that 
allodynia would transfer to a dysesthetic sensation during the successive compression-
ischemia blocking of A-beta fibres.  
 
2.1.4 Study IV 
To investigate the modulatory effect of spinal cord stimulation on somatosensory 
functions within the painful area in a larger group of patients with neuropathic pain 
following an injury to a peripheral nerve or nerve root without concomitant pain of 
non-neuropathic origin. Furthermore, we aimed at extending observations of others by 
including an analysis of the correlation between changes in somatosensory functions 
and the degree of pain relief following spinal cord stimulation. Such comparisons may 
disclose details about the link between sensory aberrations and spontaneous ongoing 
pain. 
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3 MATERIAL AND METHODS 
 
3.1 SUBJECTS 
All participating patients with neuropathic pain were out patients recruited from Pain 
Center, Department of Neurosurgery, Karolinska University Hospital, Solna or from 
Multidisciplinary Pain Center, Uppsala University Hospital. Patients without pain 
(Study I) were recruited from Department of Hand Surgery, Södersjukhuset, 
Stockholm. All patients were diagnosed by a neurologist (author P.H. or Å.L.). A 
partial peripheral nerve injury was defined as remaining sensibility of any modality in 
part of or in the entire innervation territory of the injured nervous structure and no 
history or chart notes of total anaesthesia in the same territory, indicating complete 
nerve lesion, at the time of injury.  
Exclusion criteria in patients with peripheral nerve injuries were complete nerve 
lesions, bilateral lesions of peripheral nerves, clinical signs of overt neurogenic 
inflammation or autonomic dysfunction, a diagnosis of CRPS type II, age <18 or >80 
years, pain of non-neuropathic origin in the pain affected or contralateral area, systemic 
diseases predisposing for neuropathy or severe somatic or psychiatric diseases. If the 
patient was treated with a spinal cord stimulator this had to be turned off for at least 12 
hours before examination to allow for the pain relieving effect to cease. All patients 
volunteered no remaining post stimulatory pain relief before start of the test session. 
Ongoing pharmacological treatment of the painful condition was allowed. All studies 
were performed in accordance with the Declaration of Helsinki and were approved by 
the local ethical committee of the Karolinska University Hospital, Solna and all 
subjects gave their informed consent to participation.  
 
3.1.1 Study I 
Thirty-four patients with unilateral partial peripheral traumatic nerve injury were 
studied.  
 
3.1.1.1 Patients with pain 
Eighteen patients with spontaneous ongoing pain (12 females, 6 males, median age 46 
years, range 25 – 59 years) participated. The median duration of time since nerve injury 
was 6 years (range 1 – 15 years). Inclusion criteria for patients with pain were a 
duration of pain >6 months and pain intensity immediately preceding the study 
examination of at least 30/100 on a 0 – 100 points numerical rating scale (NRS) (0 = no 
pain, 100 = worst pain imaginable). The nerve injury had not been surgically sutured in 
any of the patients reporting pain. Demographic data is shown in Table 1.  
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Table 1.  
Demographic data of patients with painful unilateral partial peripheral traumatic nerve 
injury (n=18). 
 
 
 
M, male; F, female; NRS, numerical rating scale; AMI, amitriptyline; COD, codeine; 
GAB, gabapentin; PAR, paracetamol.  
Patient 
(gender) 
Age 
(years) 
Pain 
duration 
(years) 
Injured nerve Etiology  
of nerve  
injury 
Spontaneous 
ongoing 
pain  
(NRS) 
Medication SCS 
1 M 29 10 Saphenous nerve Compartment 
syndrome, lower leg 
including  fasciotomy 
30/100 None No 
2 F 59 3 Saphenous  nerve Knee joint 
replacement surgery 
39/100 AMI No 
3 F 51 3 Radial nerve Surgery of proximal 
humerus fracture 
80/100 AMI, GAB No 
4 M 25 1 Intercostal nerves  
T5-9 
Thoracotomy due to 
pneumothorax 
40/100 None No 
5 F 48 2 Iliohypogastric 
/ilioinguinal 
nerves 
Abdominal surgery 70/100 None No 
6 F 49 2 Saphenous  nerve Compartment 
syndrome, lower leg 
including  fasciotomy 
35/100 None No 
7 F 32 8 Lateral cutaneous  
nerve of the thigh 
Laparoscopic 
abdominal surgery 
75/100 None No 
8 F 59 9 Anterior cutaneous 
nerves of the thigh 
Surgery due to 
trochanter bursitis 
50/100 None No 
9 M 47 11 Tibial nerve Stab injury and 
fasciotomy, lower leg 
50/100 None No 
10 M 29 3 Anterior cutaneous 
nerves of the thigh 
Surgery/stripping of 
varicous veins  
40/100 None No 
11 F 36 15 Sural nerve Ankle joint surgery 60/100 None No 
12 F 39 3 Superficial  
radial nerve 
Thenotomy at wrist 
level 
45/100 None No 
13 M 46 9 Tibial nerve Gun shot injury in 
the lower leg 
50/100 None No 
14 F 45 10 Tibial nerve Surgery due to local 
infection/necrosis in 
the calcaneus 
30/100 None No 
15 F 27 4 Median nerve  Carpal tunnel surgery 60/100 PAR, COD No 
16 F 37 9 Median nerve Compression due to 
humerus fracture 
45/100 None Yes 
17 M 58 6 Ulnar nerve Elbow joint surgery  70/100 None Yes 
18 F 51 5 Ulnar nerve Surgery at elbow 
level due to lipoma 
100/100 None Yes 
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3.1.1.2 Patients without pain 
Sixteen patients presented without pain (4 females, 12 males, median age 31 years, 
range 19 – 62 years). Median duration of time since nerve injury was 4 years (range 1 – 
7 years). Inclusion criteria for patients without pain were duration of > 6 months since 
the nerve injury and a subjective experience of sensory abnormality to at least one 
modality in the innervation territory of the injured nerve. In patients without pain there 
was information in the patients’ charts about the degree of nerve injury based on visual 
inspection made by the surgeon during surgery. Only partial nerve injuries were 
included. The nerve injury had been surgically sutured in all patients. Demographic 
data is shown in Table 2.  
 
Table 2.  
Demographic data of patients with unilateral partial peripheral traumatic nerve injury 
without pain (n=16). All patients had cut injuries at wrist level or distally in the hand.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M, male; F, female 
 
3.1.2 Study II 
Eighteen patients with painful unilateral partial peripheral traumatic nerve injury in a 
limb were studied (12 females, 6 males, median age 51 years, range 24 – 62 years). The 
median duration of time since nerve injury was 5 years (range 1 – 12 years). All 
patients presented with DMA and 9 patients reported concomitant SMA in the area of 
DMA. DMA was considered to be present if pain was evoked by stroking the 
neuropathic skin with a camel’s hair brush, and SMA if sustained prodding 
perpendicularly against the skin for 10 s using a q-tip was painful for the duration of the 
stimulation. No patient had any previous experience with a compression/ischemia-
induced (differential) nerve block. Inclusion criteria were duration of pain >6 months 
and only patients with DMA with or without concomitant SMA were eligible. These 
Patient 
(gender) 
Age 
(years) 
Time since injury  
(years) 
Injured nerve 
19 M 62 6 median nerve 
20 F 32 6 median nerve 
21 M 62 5 median nerve 
22 F 24 3 median nerve 
23 F 23 4 median nerve 
24 M 23 2 median nerve 
25 M 47 6 median nerve 
26 M 23 7 median nerve 
27 M 25 6 ulnar nerve 
28 M 29 1 ulnar nerve 
29 M 19 4 median nerve 
30 M 45 4 median nerve 
31 M 43 3 median nerve 
32 F 23 1 median nerve 
33 M 32 2 ulnar nerve 
34 M 35 4 ulnar nerve 
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patients also participated in another study on mechanical allodynia (Study III) and were 
examined with additional quantitative sensory testing during the same session. 
Demographic data is shown in Table 3.  
 
Table 3.  
Demographic data of patients with painful unilateral partial peripheral traumatic nerve 
injury in a limb (n=18). 
 
 
SMA, static mechanical allodynia; M, male; F, female; VAS, visual analogue scale. 
Intensity of spontaneous ongoing pain translated from a 100 mm visual analogue scale 
(VAS), graded from 0 = ‘no pain at all’ to 100 = ‘worst possible pain’, as rated during 
the clinical examination immediately preceding the experiment.  
SCS, spinal cord stimulation; CEL, celecoxib; COD, codeine; DUL, duloxetine; PAR, 
paracetamol; PRE, pregabalin; TRA, tramadol;. 
Patient 
(gender) 
Age 
(years) 
Pain  
duration 
(years) 
Injured  
nerve 
Spontaneous 
ongoing 
pain  
(VAS) 
SMA SCS Medication 
1 M 28 7 Lateral cutaneous 
nerve of the forearm 
10/100 No Yes None 
2 F 60 3 Ulnar nerve 0/100 No No None 
3 F 53 2 Brachial plexus 0/100 Yes Yes None 
4 M 30 11  Sural nerve 50/100 No No None 
5 F 24 2 Median nerve 42/100 No No None 
6 F 38 4 Lateral cutaneous 
nerve of the calf 
30/100 Yes No None 
7 F 51 3 Ulnar nerve 32/100 Yes No None 
8 M 39 5 Digital nerve of 
finger 
72/100 Yes Yes None 
9 F 51 12 Medial cutaneous 
nerve of the forearm 
80/100 Yes No PAR 
10 F 62 6 Ulnar nerve 60/100 No No PRE  
11 M 43 5 Digital nerve of 
finger 
70/100 Yes No None 
12 F 56 6 Infra patellar nerve 20/100 Yes No PAR, COD 
13 F 52 8 C8 root 55/100 Yes No PRE, DUL 
14 F 46 7 L5 root 85/100 Yes No None 
15 F 50 1 Superficial peroneal 
nerve 
65/100 No No TRA, DUL 
16 M 45 8 Superficial peroneal 
nerve 
35/100 No No None 
17 M 54 5 Ulnar nerve 30/100 No Yes None 
18 F 58 3 Median nerve 40/100 No No CEL  
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3.1.3 Study III 
Twenty five patients with neuropathic pain and DMA in a limb were included. 
Inclusion criteria were duration of pain >6 months. DMA was considered to be present 
if pain was evoked by stroking the skin with a camel’s hair brush. Before the 
experiment none of the patients presented with dysesthesia only in the area examined 
with the brush.  
 
3.1.3.1 Patients with peripheral neuropathic pain 
Eighteen patients with peripheral neuropathic pain (PNeP) due to a unilateral partial 
peripheral traumatic nerve injury in a limb were studied (12 females, 6 males, median 
age 51 years, range 24-62 years). The median duration of time since nerve injury was 5 
years (range 1-12 years).  
None of the patients with PNeP pain had undergone neurophysiological examinations. 
These patients also participated in another study on mechanical allodynia (Study II) and 
were examined with additional quantitative sensory testing during the same session. 
Demographic data is shown in Table 3.  
 
3.1.3.2 Patients with central post stroke pain 
Seven patients with central post stroke pain (CPSP) were studied (3 females, 4 males, 
median age 68 years, range 38 – 70 years). The median time of disease duration was 3 
years (range 0.25 – 11 years). All patients had their cerebral lesion verified by 
computerized tomography (CT).  
Additional exclusion criteria in this patient group were a clinical history of bilateral 
cerebrovascular lesions or bilateral lesions visible on CT, signs of cognitive 
dysfunction or neglect, marked paralysis of the painful hand and a history of injury to 
the peripheral nervous system in the contralateral non-painful limb.  
Demographic data is shown in Table 4.  
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Table 4.  
Demographic data on patients with central post stroke pain (n=7). 
 
 
VAS, visual analogue scale; Intensity of spontaneous ongoing pain translated from a 
100 mm visual analogue scale (VAS), graded from ‘no pain at all’ to ‘worst possible 
pain’, as rated during the clinical examination immediately preceding the experiment. 
AMI, amitriptyline; GAB, gabapentin; PAR, paracetamol; PRE, pregabalin; TRA, 
tramadol.  
 
Patient 
(gender) 
Age 
(years) 
Pain 
duration 
(years) 
Location of 
cerebral lesion 
(computerized 
tomography) 
Location of 
examination 
area with 
DMA 
Spontaneous 
ongoing 
pain  
(VAS) 
Medication 
19 M 69 11 left dorsal 
putamen/posterior 
internal capsule 
hemorrhage 
right hand 82/100 GAB  
TRA  
PAR 
20 F 42 2 right putamen 
hemorrhage 
left hand 66/100 GAB 
21 M 60 3 left posterior 
internal capsule  
hemorrhage/infarct
right hand 81/100 AMI  
GAB  
PAR  
22 F 70 2  right dorsolateral 
thalamus/posterior 
internal capsule 
hemorrhage 
left hand 43/100 AMI 
23 M 66 8 left dorsal basal 
ganglia/posterior 
internal capsule 
hemorrhage 
right hand 40/100 TRA 
24 F 68 11 left caudate 
nucleus, posterior 
internal capsule 
and lateral 
thalamic 
hemorrhage 
right hand 100/100 AMI 
GAB 
25 M 38 0.25 right dorsal 
putamen 
hemorrhage 
left foot 50/100 PRE 
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3.1.4 Study IV 
Sixteen patients with painful unilateral partial traumatic injury to a peripheral nerve or 
nerve root reporting pain relief from spinal cord stimulation (SCS) were studied (11 
females, 5 males, median age 48 years, range 37-64 years). The median time since 
nerve injury was 9 years (range 3 – 15 years) and median time since implant of the 
SCS-system was 2.5 years (range 3 months – 9 years). Inclusion criteria were a 
duration of spontaneous ongoing pain >6 months, time since implant of the spinal cord 
stimulator of at least 3 months and only patients reporting a sustained post stimulatory 
pain relieving effect of at least 30 % lasting no less than 45 minutes were eligible. The 
median pain relieving effect induced by SCS was 68 % (range 43 – 100%) and the 
median stimulation time to induce the usual magnitude of pain relief was 39 min (range 
30 – 60 min). Following SCS no patient reported any fading of the pain relieving effect 
during the post stimulatory examination and all rated their pain intensity identical 
before and after the examination. Only 5/16 patients participating had undergone 
magnetic resonance tomography and 1/16 patients neurophysiological examination 
confirming the diagnosis of injury to a nervous structure. Therefore, the diagnosis of 
neuropathic pain can merely be assessed with the highest degree of certainty, i.e., 
‘definite’ neuropathic pain, in 6/16 patients according to the recently proposed grading 
system (Treede et al., 2008). Hence, we only claim that ‘probable’ neuropathic pain 
was at hand in 10/16 patients. Demographic data is shown in Table 5.  
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Table 5.  
Demographic data on patients with painful unilateral partial traumatic injury to a 
peripheral nerve or nerve root reporting pain relief from spinal cord stimulation (n=16).  
 
 
 
 
 
M, male; F, female; NRS, numerical rating scale; SCS, spinal cord stimulation; AMI, 
amitriptyline; COD, codeine; GAB, gabapentin; PAR, paracetamol; TRA, tramadol. 
Patient 
(gender) 
Age 
(years) 
Pain 
duration 
(years) 
Injured 
nervous 
structure 
Duration 
since  
implant  
of SCS 
(years 
/months) 
Spontaneous 
ongoing 
pain before 
SCS  
(NRS) 
Spontaneous 
ongoing 
pain  
after SCS  
(NRS) 
Stimulation 
time  
(min) 
Medication 
1 F 63 5 left S2 
root 
2 70/100 30/100 40 None 
2 M 47 11 right S1 
root  
7 50/100 20/100 30 AMI, PAR,  
TRA 
3 F 37 9 right 
median 
nerve 
7 45/100 5/100 40 None 
4 F 64 3 left L5 
root 
6 months 50/100 25/100 40 TRA 
5 F 56 5 left 
brachial 
plexus 
4 70/100 40/100 40 COD, PAR 
6 F 44 11 left L5 
root 
9 30/100 0/100 40 None 
7 M 48 4 left ulnar 
nerve 
3 months 70/100 40/100 50 None 
8 F 38 10 right S1 
root 
9 months 40/100 20/100 60 None 
9 F 51 7 right 
ulnar 
nerve 
10 
months 
100/100 10/100 35 None 
10 M 60 9 right L5 
root 
7 40/100 10/100 32 PAR 
11 F 46 9 right 
intercostal 
nerves 
T8-T10 
5 70/100 10/100 40 None 
12 F 41 6 left S1 
root 
3 80/100 45/100 30 None 
13 M 50 10 right L5 
root 
3 months 50/100 10/100 35 None 
14 M 56 4 right L5 
root 
2 50/100 0/100 37 None 
15 F 47 11 right L5 
root 
8 70/100 40/100 32 None 
16 F 44 15 left S1 
root 
1 30/100 5/100 30 GAB 
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3.2 METHODS 
 
3.2.1 General procedure 
The diagnosis of neuropathic pain was based on a history of injury to a peripheral nerve 
or nerve root or a cerebrovascular lesion, a distribution of pain corresponding to the 
peripheral innervation territory of the injured nervous structure or to the topographic 
representation of the body part in the lesioned CNS area in conjunction with findings of 
sensory abnormalities within the area of pain at bedside examination. To guide 
sensibility testing patients were asked to indicate the area of spontaneous ongoing pain, 
DMA and SMA (if present) and in patients without pain the area of subjective sensory 
disturbance on a body drawing. Before the test session patients were asked to rate the 
intensity of spontaneous ongoing pain on a 100 mm visual analogue scale (VAS) 
(Study II and III) or on a 0 – 100 points numerical rating scale (NRS) (0 = no pain, 100 
= worst pain imaginable) (Study I and IV). All patients underwent a neurological 
examination by author Å.L. including a bedside examination of the somatosensory 
systems (touch, warmth, cold and pin prick) as part of the diagnostic work-up. 
Somatosensory functions were also monitored by quantitative sensory testing (QST), 
see below. All tests and sensibility assessments were performed by author Å.L. in a 
quiet room with the patient comfortably seated in a chair or lying in a relaxed supine 
position on a bed. Before the test session patients were carefully familiarized with the 
different methods to be used and to the testing procedure. The patients were instructed 
to keep their eyes closed during the tests and were unaware of the test results during the 
session. To assure that the subsequent assessments all were made in the same location 
an examination point/area was marked with a pen. Care was taken to choose an 
examination point/area within the area of sensory aberration or maximum pain, DMA 
or SMA where the examination device was possible to apply and to stimulate the same 
point/area for all types of stimuli. All sensibility testing was done first in the 
corresponding contralateral non-injured area and then in the projection area of the 
injured nervous structure or in the topographic representation of the body part in the 
lesioned CNS area. The method of limits was used in all quantitative testing of 
somatosensory perception thresholds except in testing the perception threshold to light 
touch using von Frey filaments where the method of levels was used. 
 
3.2.1.1 Study I 
Perception thresholds to warmth, cold, light touch, pressure pain, cold- and heat pain 
were assessed as were pain intensities at suprathreshold heat pain stimulation. In 
patients with pain the testing was made within the area of maximum pain and in 
patients without pain in the area with sensory disturbance. 
 
3.2.1.2 Study II and III 
Baseline sensibility testing, i.e., perception thresholds to light touch, cold, warmth, 
cold- and heat pain was made to get an estimation of the degree of sensory dysfunction 
in the area of DMA/SMA. In the neuropathic area also pain perception thresholds to 
von Frey filament stimulation of 1 s and 10 s were assessed. Finally, a control area with 
no signs of neuropathy was examined to obtain baseline values for cold and warm 
perception thresholds subsequently used to monitor the progression of a 
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compression/ischemia-induced (differential) nerve block of the painful limb. In patients 
with PNeP the control area was located neighbouring the neuropathic area at the same 
proximo-distal level but in patients with CPSP the control area was located in the 
corresponding homologous non-painful area. 
 
3.2.1.3 Study IV 
In all patients perception thresholds to warmth, cold, light touch, pressure pain, cold- 
and heat pain were assessed as were pain intensities at suprathreshold heat pain 
stimulation. Half of the patients were examined with mechanical stimulation preceding 
thermal stimulation and the other half in the reverse order. The patients were then 
instructed to turn on the spinal cord stimulator and stimulate with their regular duration 
of stimulation until their usual level of pain relief was obtained. Stimulation time varied 
between 30-60 minutes. The spinal cord stimulator was then turned off and patients 
were re-examined in the neuropathic area. Both immediately before and after the post 
stimulatory examination patients were asked to rate the intensity of spontaneous 
ongoing pain. The post stimulatory testing protocol lasted approximately 20 min.  
 
3.2.2 Quantitative sensory testing 
3.2.2.1 Perception threshold to light touch 
Perception threshold to light touch was assessed using a set of 15 von Frey filaments 
(OptiHair®, Marstock-nervtest, graded from 0.29 mN (0,03 gram) to 294 mN (30 
gram) (logarithmical increase) (Fruhstorfer et al., 2001) made of optical glass fibre. To 
keep the contact surface approximately constant for various fibre diameters the tip of 
the fibre is coated with a tiny round epoxy bead (diameter about 0.5 mm). This may 
also reduce the risk of nociceptor activation compared to conventional nylon 
monofilaments with sharp edges (Greenspan and McGillis, 1991; Magerl et al., 1998). 
Care was taken to apply the filaments perpendicularly to the surface of the skin and 
avoiding contact with body hair, shaving the skin if necessary. The light touch 
perception threshold (LTT) in each area was calculated as the mean value of five 
descending and five ascending assessments (Kosek et al., 1996). 
 
3.2.2.2 Pain perception thresholds to von Frey filament stimulation (Study II) 
Pain perception thresholds to mechanical stimulation were assessed using the same set 
of von Frey filaments as the LTT (see above). We used a stimulus duration of 
approximately 1 s or 10 s aiming at assessing the perception threshold counterpart to 
DMA and SMA. The baseline von Frey pain perception thresholds were defined as the 
lowest pressure considered painful for the different stimulus duration of 1 s (vF1) and 
10 s (vF10), respectively. All patients were examined with both stimulus durations, the 
short stimulus always preceding the longer one. The average of three ascending 
perception levels was calculated as the baseline von Frey pain perception threshold.   
Importantly, the von Frey filaments used in the study did not evoke pain in the 
contralateral pain free area or in the control area neighbouring the neuropathic skin in 
any patient.  
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3.2.2.3 Pressure pain threshold (Study I and IV) 
The pressure pain threshold (PPT) was assessed using a pressure algometer (Somedic 
Sales AB, Hörby, Sweden). A circular padded probe with an area of 1 cm² was used 
and the perception level to pressure pain was assessed three times, with an average 
pressure application rate of 50 kPa/s and an interstimulus interval of 15 seconds. The 
patients were instructed to press a hand-held button as soon as the pressure turned into a 
painful sensation, whereby the pressure value was frozen on a digital display. The mean 
value of the last two perception levels was calculated as the PPT.  
 
3.2.2.4 Thermal perception thresholds 
Thermal thresholds were assessed using a Peltier element based thermode of 12.5 cm² 
(Modular Sensory Analyser, Somedic Sales AB, Hörby, Sweden) applied to the skin. If 
necessary the thermode was secured to the skin with an elastic bandage to keep it in 
place, care taken to apply minimal pressure. The baseline temperature of the thermode 
was set equal to the skin temperature assessed with the infrared skin temperature 
analyzer Tempett® (Somedic Sales AB, Hörby, Sweden) and then adjusted manually 
until the patient perceived the sensation of the thermode as indifferent. The perception 
thresholds to non-painful cold (CT) and warmth (WT) were obtained by delivering five 
cold followed by five warm stimuli with a preset randomised inter-stimulus interval of 
4-10 s and with a stimulus rate of 1ºC/s. The patients were instructed to press a hand-
held button at the first sensation of cold or warmth, respectively, thereby terminating 
the stimulus. Thresholds were calculated as the average temperature difference from 
skin temperature (baseline) of five successive perception levels (∆CT, ∆WT).  
The noxious temperatures were delivered manually. The patients were instructed to 
press a hand-held button at the first sensation of pain thereby terminating the stimulus. 
The perception thresholds to heat- (HPT) and cold pain (CPT) were calculated as the 
mean value of three (Study I) or as the mean value of the last two of three (Study IV) 
successive perception levels with a stimulus rate of 1ºC/s and an inter-stimulus interval 
of 30 seconds. To avoid tissue damage the maximum temperature was set at 50ºC and 
the minimum temperature at 5 (Study II and III) or 10ºC (Study I and IV), respectively. 
Failure to respond before the cut-off limit was reached resulted in assignment of the 
cut-off value.  
 
3.2.2.5 Suprathreshold heat pain stimulation (Study I and IV) 
The sensitivity to suprathreshold heat pain (SHP) was assessed with a stimulus rate of 
1ºC/s and an inter-stimulus interval of 3 minutes. To avoid tissue damage the maximum 
temperature was set at 50ºC. The patients were instructed to push the button 
immediately when they would rate the heat pain intensity as 60 out of 100 on a NRS 
(SHP 60/100). SHP 60/100 was calculated as the mean value of two successive 
measurements. To be able to create stimulus-response functions for suprathreshold heat 
pain the interval between HPT and SHP 60/100 was divided into three equal parts thus 
defining two additional suprathreshold temperatures (SHP 1 and 2) which were 
delivered twice and in random order. The patients were asked to rate the perceived pain 
intensity immediately following each stimulus. The mean value of the two pain ratings 
for each temperature was calculated and used to plot the stimulus-response functions. 
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3.2.3 Compression-ischemia induced (differential) nerve block 
To study which nerve fibre population that contributes to pain at 1 and 10 s prodding of 
the skin with von Frey filaments (Study II) and to DMA and DMD (Study III) a 
compression/ischemia-induced (differential) nerve block approach was used (Gasser 
and Erlanger, 1929; Ochoa and Yarnitsky, 1993). This was obtained through inflation 
of a sphygmomanometer cuff proximally placed around the symptomatic limb, 
inflating it to a level of 80 to 100 mm Hg above the systolic blood pressure (Ochoa and 
Yarnitsky, 1993). Shortly after inflating the cuff all patients experienced spontaneous 
non-painful paresthesias in the painful limb. This sensation vanished after a few 
minutes. The patients were carefully instructed not to move the limb during the course 
of the block since this may induce paresthesias or pain which may affect the outcome 
of the testing procedure.  
During the nerve block single perception levels to cold (CL) and warmth (WL) were 
assessed every 1-3 minutes in the control area. This was done to monitor function in A-
delta (cold) and C-fibres (warmth) during progression of the block. A significant 
elevation of a thermal perception level during the nerve block was defined as a 
sustained increase of at least 2 standard deviations (SD) compared to the individual pre-
block mean. Also, the perception magnitude from brushing (normal, increased, 
decreased or none) the skin with a camel’s hair brush (three times over the length of 
about 2 cm with a velocity of approximately 2 cm/s) in the control area compared to the 
contralateral pain free area (in patients with PNeP) or compared to an area just 
proximal to the cuff (in patients with CPSP) were assessed at the same intervals to 
monitor A-beta-fibre function (touch). The nerve block was terminated if the patient 
did not tolerate the pain caused by the cuff, if the spontaneous ongoing pain in the limb 
became unbearable, if a total loss of touch- and cold sensation indicating block of all A-
fibres was obtained or at a maximum blocking time of 45 minutes. If the nerve block 
was terminated before significant elevation of CL and WL was obtained the time point 
of termination was assigned as the time point for elevation of CL and WL to allow for 
group level statistical analysis.  
 
3.2.3.1 Study II 
During the block single von Frey pain perception levels to 1 s (vF1) and 10 s (vF10) 
stimulation were repeatedly assessed every 1 – 3 minutes in the neuropathic area by 
single ascending stimuli. An increase in the pain perception level to von Frey filament 
stimulation of at least 2 steps (logarithmical increase) of the bending threshold during 
the block compared to pre-block values was regarded a significant increase.  
 
3.2.3.2 Study III 
3.2.3.2.1 Patients with PNeP 
To assess the perceptual details of brush-induced DMA/DMD the patient was explicitly 
asked to describe the perception from brushing the skin with a camel’s hair brush in the 
neuropathic area (three times over the length of about 2 cm with a velocity of 
approximately 2 cm/s) by choosing from the descriptors painful, unpleasant, normal 
touch or no sensation every 1 – 3 minutes during the block.  
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3.2.3.2.2 Patients with CPSP 
In patients with CPSP an indirect method was employed to monitor progression of the 
nerve block compared to in patients with PNeP. Since all patients with CPSP had a 
lesion to the spino-thalamo-cortical pathway it was not possible to monitor progression 
of a nerve block in the painful limb in all patients due to sometimes marked impairment 
of temperature sensibility. Thus the nerve block was first performed in the non-painful 
contralateral limb to get a ‘time table’ of when the different types of nerve fibres were 
affected. The sensation to brushing in the contralateral control area during the block 
was compared to an area just proximal to the cuff. The time to loss of sensation to 
touch in the control area and to elevation of CL and WL were recorded. After 
conducting the nerve block on the non-painful side there was a recess of at least 30 
minutes to allow for paresthesiae after the nerve block to disappear. In patients with 
pain located in the hand (n=6) the recess was necessary to allow for the non-painful 
hand to regain full motor function. The nerve block was then performed in the painful 
limb and the perception of brush-induced DMA/DMD was assessed in the painful area 
every 1 – 3 minutes (see above). The protocol was finally completed with data from the 
previous nerve block in the non-painful limb, i.e., time to loss of sensation to touch and 
time to elevation of CL and WL. The time line of the experimental procedure is 
presented in Fig.1. An illustrative case is depicted in Fig. 2.  
 
 
 
 
 
 
 
 
Fig. 1. Time course of the experiment. CONTRALAT, contralateral pain-free area; 
NEUROPAT, neuropathic area; CONTROL, control area neighbouring the painful site; 
CL, perception level to cold; WL, perception level to warmth; vF1, pain perception 
level to 1 s von Frey filament stimulation; vF10, pain perception level to 10 s von Frey 
filament stimulation. 
 
Compression/ischemia-induced (differential) 
nerve block
Neurological
examination
Assessments cyclically every 1-3 min
CONTROL - CL, WL, brushing
NEUROPAT - vF1, vF10
Baseline assessments
(CONTRALAT)
Baseline assessments
(NEUROPAT)
Baseline assessme nts
(CONTROL )
Cuff inflation Cuff deflation
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Fig. 2. Illustrative case of a patient during the compression/ischemia block. 
CL, perception level to cold; WL, perception level to warmth; vF1, pain perception 
level to 1 s von Frey filament stimulation; vF10, pain perception level to 10 s von Frey 
filament stimulation. 
(___), loss of sensation to touch in the control area 
(----), elevation of CL in the control area 
(-.-.-), elevation of WL in the control area 
        , elevation of vF1 or vF10 
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3.3 STATISTICS 
Statistical significance was accepted at p<0.05. Data was analysed using Statistica 8.0, 
StatSoft®, Inc. Tulsa OK, USA. 
 
3.3.1 Study I 
Since most data variables had a non-symmetric distribution non-parametric statistics 
were applied. The test results from each side were compared within each patient group 
to probe intra-group side differences and then the calculated side-to-side difference was 
used to compare the two groups of patients. The difference between the two sides was 
calculated as the mean value obtained from the injured side – mean value from the 
contralateral side  Analysis of the difference between sides in each group separately 
was performed by the Sign Test (Siegel and Castellan, 1988) (non-parametric data). 
The difference between sides for each parameter within each group was compared 
between the two patient groups using the Mann-Whitney U Test. The analysis of the 
stimulus-response functions for suprathreshold heat pain was made by calculating 
individual linear regression. The individual regression coefficients were then analysed 
within and between groups using Sign Test and the Mann-Whitney U Test. Data is 
presented as median and inter-quartile range.  
 
3.3.2 Study II 
Data was normally distributed. Results were analysed using a one-way ANOVA with 
repeated measures on factor “time” with 3 or 4 levels (time to elevation of vF1 and/or 
vF10, CL and WL). If the F-ratio for the main effect of “time” was significant, Fisher’s 
LSD test or Tukey test was performed depending on the number of factor levels. When 
comparing patients with and without SMA data was analysed using a two-way 
ANOVA with repeated measures with the between-group factor ‘SMA’ with 2 levels 
(yes/no) and the within-group factor ‘time’ with 3 levels (time to elevation of vF1, CL 
and WL). If a significant interaction between ‘SMA’ and ‘time’ was found, simple 
main effects tests were performed, i.e., effects of one factor holding the level of the 
other factor fixed. If no significant interaction with factor ‘time’ was present and the F-
ratio for the main effect of ‘time’ was significant, Fisher’s LSD test was performed. 
The sphericity assumption was met in all the ANOVA models. T-test was used 
comparing time to elevation of vF10 in patients with SMA with time to elevation of 
vF1 in patients without SMA.  
 
3.3.3 Study III 
Data was normally distributed. Results were analysed using a one-way ANOVA with 
repeated measures on factor ‘time’ with 4 levels (time to transition/loss of DMA, time 
to elevation of CL and WL and time to loss of touch in the control area). If the F-ratio 
for the main effect of ‘time’ was significant Tukey test was performed. When 
comparing patients with PNeP and CPSP data was analysed using a two-way ANOVA 
with repeated measures with the between-group factor ‘group’ with 2 levels 
(PNeP/CPSP) and the within-group factor ‘time’ with 4 levels (time to transition/loss of 
DMA, time to elevation of CL and WL and time to loss of touch in the control area). In 
case of a significant interaction between ‘group’ and ‘time’, simple main effects tests 
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were performed, i.e., effects of one factor holding the other factor fixed. The sphericity 
assumption was met in all the ANOVA models.  
 
3.3.4 Study IV 
Results were analysed using a one-way ANOVA with repeated measures on factor 
‘side’ with 3 levels (the injured side before and after SCS as well as the contralateral 
side before SCS). If the F-ratio for the main effect of ‘side’ was significant, post hoc 
analysis using Fisher’s LSD test or t-test was performed. Due to skewed distribution for 
LTT and ∆CT these data have been log-transformed in order to meet the requirements 
for an adequate ANOVA. Due to a ceiling/floor effect of the variables PPT, SHP and 
CPT a non-parametric statistic approach with Mann-Whitney U-test and Friedman 
ANOVA was used. The correlation between the degree of change in perception 
threshold level on the injured side after SCS versus the degree of pain relief induced by 
SCS was calculated for each parameter using Spearman rank order correlation.  
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4 RESULTS 
 
4.1 STUDY I 
 
4.1.1 Side comparisons of sensibility in patients with pain  
Four patients in the pain group (nos. 5, 8, 10, 15) reported dynamic mechanical 
allodynia to brushing in the area of neuropathy and all experienced pain instead of 
touch as the first sensation when testing with von Frey filaments. Hence LTT data is 
missing in these patients. When assessing the PPT on the painful side all 4 patients 
reported pain when placing the pressure algometer device against the skin and PPT 
could therefore not be assessed. Three patients were treated with a spinal cord 
stimulator and were requested to switch it off at least 12 hours before examination to 
eliminate the pain relieving effect.  
Table 6 summarizes the outcome of QST on a group level. Patients with pain presented 
with an increased threshold to warmth (∆WT) on the injured side but no difference 
could be demonstrated for the perception threshold to cold (∆CT). There was an 
increased sensitivity to cold pain and pressure pain with decreased thresholds to CPT 
and PPT on the injured side but no difference could be demonstrated regarding HPT, 
SHP 60/100 or LTT. No difference between sides regarding stimulus-response function 
for suprathreshold heat pain could be demonstrated (p=0.75). Individual QST data is 
presented in Table 7.  
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Table 6.  
Thermal and mechanical perception thresholds in the pain group (n=18) and in the pain 
free group (n=16). 
 
 
 
 
Threshold values are presented as medians with [25th and 75th percentiles]. 
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal  
* , significant difference with p< 0.05 (Sign test), injured side compared to uninjured 
side. 
Test parameter Group No. of 
tested 
patients 
Contralateral area Nerve injured area  p value 
Thermal      
∆WT/ºC Pain 18 3.2 [2.1 ; 5.1] 4.1 [2.8 ; 10.7] 0.024* 
 Pain free 16 1.8 [1.5 ; 2.4] 2.5 [2.0 ; 5.3] 0.001* 
∆CT/ºC Pain 18 1.2 [1.0 ; 1.6] 1.7 [0.9 ; 3.0] 0.24 
 Pain free 16 1.3 [1.1 ; 1.6] 1.7 [1.1 ; 2.2] 0.039* 
CPT/ºC Pain 18 10.0 [10.0 ; 18.7] 23.4 [14.4 ; 28.5] 0.003* 
 Pain free 16 10.0 [10.0 ; 19.8] 17.5 [10.0 ; 23.2] 0.07 
HPT/ºC Pain 18 44.8 [43.3 ; 47.4] 42.6 [36.6 ; 48.1] 0.48 
 Pain free 16 43.1 [40.4 ; 46.1] 40.4 [38.4 ; 46.4] 0.30 
SHP 60/100 /ºC Pain 12 47.8 [45.0 ; 48.7] 47.3 [39.5 ; 49.1] 0.75 
 Pain free 10 48.7 [47.8 ; 49.7] 46.1 [43.3 ; 48.7] 0.29 
Mechanical      
LTT/g Pain 18/14 0.318 [0.095; 0.607] 0.318 [0.168; 0.567] 0.27 
 Pain free 16 0.050 [0.030 ; 0.124] 0.250 [0.151; 0.794] 0.002* 
PPT/kPa Pain 18/14 228 [130 ; 269] 101 [44 ; 187] 0.016* 
 Pain free 16 276 [200 ; 392] 265 [142 ; 366] 0.21 
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Table 7.  
Individual thermal and mechanical perception thresholds in the pain group (n=18). 
 
 
Pat LTT  
g 
Con 
LTT 
g 
Inj 
PPT 
kPa 
Con 
PPT 
kPa 
Inj 
∆CT
ºC 
Con 
∆CT 
ºC 
Inj 
∆WT 
ºC 
Con 
∆WT 
ºC 
Inj 
CPT 
ºC 
Con 
CPT 
ºC 
Inj 
HPT
ºC 
Con 
HPT
ºC 
Inj 
1 0.61 0.32 462 197 2.4 13.7 11.6 14.6 10.0 10.0 44.7 50.0 
2 0.61 0.17 218 87 1.3 0.9 4.2 9.0 10.0 28.5 48.2 38.8 
3 0.13 0.25 242 187 1.1 0.9 4.4 1.8 10.0 22.2 46.2 38.5 
4 1.26 3.10 204 435 1.9 21.5 5.1 18.5 10.0 10.0 44.2 50.0 
5 0.32 # 269 # 1.1 3.0 2.1 3.4 10.0 30.1 46.2 34.3 
6 0.32 0.32 288 114 1.2 1.9 5.8 11.4 10.0 10.0 36.8 48.1 
7 0.61 0.03 105 72 1.5 0.9 10.2 4.1 26.1 30.7 47.4 45.8 
8 0.18 # 247 # 1.6 2.9 3.2 3.4 18.7 26.5 43.3 35.8 
9 0.09 0.57 207 42 1.2 2.1 8.4 8.4 22.9 24.5 47.4 44.5 
10 0.61 # 238 # 1.0 0.8 2.8 2.8 28.0 28.8 43.1 33.6 
11 0.10 0.39 138 44 0.9 1.3 2.2 3.1 22.7 26.9 44.5 42.6 
12 0.09 0.17 299 162 0.4 1.1 0.6 1.5 10.0 10.0 44.6 42.5 
13 0.32 0.53 92 209 1.8 2.2 3.1 6.0 17.2 14.4 48.3 49.3 
14 0.61 0.22 130 28 1.0 1.5 2.0 15.3 10.0 20.5 40.3 44.7 
15 0.03 # 340 # 1.0 0.8 1.7 1.6 10.0 32.4 49.4 38.0 
16 0.03 0.16 105 48 1.1 0.9 1.1 1.9 14.7 19.7 44.8 36.6 
17 0.28 0.61 238 180 2.6 3.6 3.5 10.7 10.0 21.0 45.5 48.3 
18 0.61 12.2 63 15 1.6 3.9 2.5 4.0 17.7 27.5 34.7 35.3 
 
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal; #, missing data; Con, contralateral side; 
Inj, injured side. 
 
 
 
4.1.2 Side comparisons of sensibility in patients without pain 
The outcome of QST on a group level is summarized in Table 6. Patients without pain 
presented with increased perception thresholds to light touch (LTT), cold (∆CT) and 
warmth (∆WT) on the injured side but no difference could be demonstrated regarding 
painful thermal or mechanical parameters (CPT, HPT, SHP 60/100 or PPT). No 
difference between sides regarding stimulus-response function for suprathreshold heat 
pain could be demonstrated (p=0.18). Individual QST data is presented in Table 8.  
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Table 8.  
Individual thermal and mechanical perception thresholds in the pain-free group (n=16).  
 
 
 
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal; Con, contralateral side; Inj, injured side. 
 
 
 
4.1.3 Side-to-side differences of sensibility between groups  
No significant side-to-side difference of any of the mechanical or thermal perception 
thresholds or stimulus-response function for suprathreshold heat pain could be 
demonstrated between the two groups of patients with and without pain (Table 9).
Pat LTT  
g 
Con 
LTT 
g 
Inj 
PPT 
kPa 
Con 
PPT 
kPa 
Inj 
∆CT 
ºC 
Con 
∆CT 
ºC 
Inj 
∆WT 
ºC 
Con 
∆WT 
ºC 
Inj 
CPT
ºC 
Con 
CPT 
ºC 
Inj 
HPT 
ºC 
Con 
HPT
ºC 
Inj 
19 0.10 0.82 722 673 2.3 2.6 2.6 6.1 10.0 10.0 50.0 50.0 
20 0.05 0.23 193 148 1.2 1.1 1.8 2.2 13.0 15.8 40.1 37.5 
21 0.03 1.06 338 191 1.1 1.1 1.7 2.5 10.0 27.2 36.0 38.0 
22 0.03 0.13 159 136 0.9 0.9 1.3 1.4 19.2 23.8 40.6 38.7 
23 0.03 0.08 362 442 1.1 2.4 1.5 4.5 10.0 18.2 44.2 40.0 
24 0.32 0.83 290 206 1.3 1.9 1.7 6.3 15.3 16.7 46.0 49.1 
25 0.32 0.32 409 292 1.3 1.4 2.0 1.6 10.0 10.0 42.8 40.3 
26 0.03 0.26 205 349 1.2 1.5 2.4 3.4 10.0 24.6 46.2 44.1 
27 0.06 0.49 195 121 1.4 1.1 1.5 2.0 20.3 26.6 38.6 38.1 
28 0.03 0.24 258 270 1.4 2.4 2.0 2.3 23.2 22.5 43.2 40.5 
29 0.07 0.04 408 280 1.1 1.6 1.4 2.0 10.0 10.0 46.5 47.6 
30 0.06 0.17 434 260 1.7 2.0 2.4 3.9 10.0 22.3 40.2 37.5 
31 0.16 0.17 376 423 1.7 1.8 5.6 9.5 20.6 20.7 45.7 45.1 
32 0.03 1.12 252 87 1.0 1.1 1.3 1.9 20.4 16.8 42.9 44.6 
33 0.15 0.77 140 61 1.2 1.8 1.3 2.4 10.0 10.0 41.6 39.6 
34 0.03 0.03 262 383 1.8 2.9 2.6 6.5 10.0 10.0 48.0 50.0 
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Table 9.  
Comparisons of side-to side differences of thermal and mechanical quantitative sensory 
testing in patients with (n=18) and without pain (n=16) after nerve injury. 
 
Test parameter Pain group Pain free group p value 
Thermal    
Diff ∆WT/ºC 1.1 [0.0 ; 4.8] 0.9 [0.5 ; 3.3] 0.80 
Diff ∆CT/ºC 0.6 [-0.2 ; 1.3] 0.3 [0.1 ; 0.6] 0.43 
Diff CPT/ºC 5.2 [0.0 ; 11.8] 0.0 [-0.4 ; 6.9] 0.22 
Diff HPT/ºC -2.3 [-7.9 ; 4.5] -0.6 [-2.8 ; 1.9] 0.47 
Diff SHP 60/100/ºC -0.7 [-8.5 ; 4.3] -2.5 [-3.6 ; 0.3] 0.92 
Mechanical    
Diff LTT/g 0.124 [-0.289; 0.330] 0.197 [0.031; 0.565] 0.42 
Diff PPT/kPa -76 [-137; -48] -62 [-123; 30] 0.38 
 
Diff, side-to-side differences presented as medians with [25th and 75th percentiles], 
obtained by subtracting the uninjured side from the injured side. 
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal 
 
 
 
4.2 STUDY II 
Nine patients reported concomitant SMA in the area of DMA. Six patients had ongoing 
pharmacological treatment of their neuropathic pain. Four patients were treated with a 
spinal cord stimulator. 
 
4.2.1 Pain perception threshold to von Frey filament stimulation 
In the neuropathic area all patients reported pain from the 1 s von Frey stimulation 
(Table 10). Only patients with clinically established SMA (n=9) reported sustained pain 
during the von Frey filament stimulation of 10 s (Table 10). Patients with only DMA 
reported pain during the initial 1 – 3 s of the total stimulus duration of 10 s and for a 
few s after the filament was removed.   
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Table 10.  
Details of changes in mechanical pain perception levels during the nerve-block. 
 
 
(  ), unaltered thermal perception level; (  ), elevation of thermal perception level;  
( - ), not applicable in patients without static mechanical allodynia;  
vF1 elev., elevation of the 1 second von Frey pain perception level; vF10 elev., 
elevation of the 10 seconds von Frey pain perception level; CL, perception level to cold 
at elevation of F1/vF10; WL, perception level to warmth at elevation of vF1/vF10. 
 
 
4.2.2 Time to threshold elevation of vF1  
In the one-way ANOVA, there was a significant difference between time to elevation 
of vF1, CL and WL (n=18) during the differential nerve block (F (2, 34) = 37.65, 
p<0.001). In the post hoc analysis using Fisher’s LSD test, elevation of vF1 occurred 
significantly prior to elevation of both CL (p<0.001) and WL (p<0.001) (Fig. 3). 
Comparing patients with (n=9) and without SMA (n=9) in the two-way ANOVA, no 
significant main effect of group could be demonstrated (F (1, 16) = 0.02, p=0.89). 
There was a significant difference between time to elevation of vF1, CL and WL during 
the differential nerve block within each group (F (2, 32) = 36.02, p<0.001). This 
analyses did not reveal a significant interaction (F (2, 32) = 0.26, p=0.77) between the 
factors ‘time’ (time to elevation of vF1, CL and WL) and ‘group’ (SMA yes/no) and 
thus no significant difference in time to elevation of vF1 between patients with and 
without SMA could be demonstrated (p=0.77) (Table 11). In the post hoc analysis 
Pat 
 
vF1  
pre-
block  
(g) 
Time to 
elev. of 
vF1  
(min) 
vF1 
elev.  
(g) 
CL
 
 
WL 
 
vF10 
pre-
block  
(g) 
Time to 
elev. of 
vF10 
(min) 
vF10 
elev. 
(g) 
CL 
 
 
WL 
 
1  4.50 17.0 10.0   - - - - - 
2  4.50 3.5 10.0   - - - - - 
3  0.225 4.5 0.82   1.54 12.0 4.50   
4  0.225 3.0 30.0   - - - - - 
5  0.45 5.0 1.54   - - - - - 
6  2.65 2.0 10.0   2.65  2.0 7.0   
7  4.50 3.5 22.0   4.50  3.5 22.0   
8  0.03 6.0 0.45   0.03  6.0 0.45   
9 0.82 6.5 2.65   0.45 14.0 1.54   
10 2.65 3.0 10.0   - - - - - 
11 0.45 2,0 22.0   0.45 2.0 22.0   
12 4.50 8.0 10.0   4.50 8.0 10.0   
13 15.0 16.0 30.0   15.0 10.0 30.0   
14 0.125 3.0 4.50   0.125 3.0 7.0   
15 7.0 8.0 15.0   - - - - - 
16 0.07 3.0 0.45   - - - - - 
17 0.45 4.0 2.65   - - - - - 
18 0.225 7.0 1.54   - - - - - 
   29 
using Fisher’s LSD test, time to elevation of vF1 occurred significantly prior to both 
time to elevation of CL (p<0.001) and WL (p<0.001) (Fig. 4). At the time of vF1 
elevation 3/18 patients (nos. 1, 3, 7) presented with an elevated CL of ≥2 SD (an 
increase of 3.5 ˚C, 1.8 ˚C and 1.3˚C, respectively). None of the patients reported altered 
perception level to warmth at the time of elevation of vF1 (Table 10).  
Fig. 3. The relationship between time to elevation of vF1, CL and WL (n=18). Mean 
time to elevation and 95 % confidence intervals are presented. In the one-way ANOVA 
significant differences are indicated by p-values in the figure (** p<0.01, *** p<0.001). 
vF1, pain perception level to 1 s von Frey filament stimulation; CL, perception level to 
cold; WL, perception level to warmth.  
Fig. 4. The relationship between presence of SMA and time to elevation of vF1, CL 
and WL in patients with DMA only (n=9) and in patients with concomitant SMA (n=9) 
Mean time to elevation and 95 % confidence intervals are presented. In the two-way 
ANOVA significant differences are indicated by p-values in the figure (** p<0.01,  
*** p<0.001). vF1; pain perception level to 1 s von Frey filament stimulation;  
CL, perception level to cold; WL, perception level to warmth. 
CL WLvF1
CLvF1 WL
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4.2.3 Time to threshold elevation of vF10  
In the one-way ANOVA, there was a significant difference between time to elevation 
of vF1, vF10, CL and WL in patients with SMA (n=9) during the differential nerve 
block (F (3, 24) = 17.32, p<0.001). In the post hoc analysis using Tukey test elevation 
of vF10 occurred significantly prior to both elevation of CL (p<0.05) and WL 
(p<0.001) (Fig. 5). At the time of elevation of vF10, 2/9 patients (nos. 3, 7) presented 
with an elevated cold perception level of ≥ 2 SD (an increase of 3.4 ˚C and 1.3 ˚C, 
respectively). None of the patients reported altered perception level to warmth at the 
time of elevation of vF10 (Table 10).  
 
 
 
 
 
 
Fig. 5. The relationship between time to elevation of vF1, vF10, CL and WL in patients 
with DMA and concomitant SMA (n=9).  
Mean time to elevation and 95 % confidence intervals are presented.  
In the one-way ANOVA significant differences are indicated by p-values in the figure 
(* p<0.05, *** p<0.001).  
ns, non-significant; vF1, pain perception level to 1 s von Frey filament stimulation; 
vF10, pain perception level to 10 s von Frey filament stimulation; CL, perception level 
to cold; WL, perception level to warmth. 
 
CL WLvF10vF1
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4.2.4 The relationship between vF1 and vF10 
There was no significant difference in time to elevation of vF10 in patients with SMA 
compared to time to elevation of vF1 in patients with SMA (p=0.98, one-way ANOVA, 
Tukey test) or compared to time to elevation of vF1 in patients without SMA (p=0.72, 
t-test) (Table 11). 
 
Table 11.  
Relationship between time to elevation of vF1 and vF10. 
 
 vF1 DMA vF1 SMA vF10 SMA 
vF1 DMA  NS, p=0.77¹ NS, p=0.72² 
vF1 SMA   NS, p=0.98³ 
 
vF1, 1 s von Frey pain perception level; vF10, 10 s von Frey pain perception level; 
DMA, patients with dynamic mechanical allodynia only; SMA, patients with dynamic 
and static mechanical allodynia; NS, non-significant; ¹ = Result of two-way ANOVA, 
Fisher’s LSD test; ² = Result of t-test; ³ = Result of one-way ANOVA, Tukey test. 
 
 
4.3 STUDY III 
Six patients with PNeP and all of the patients with CPSP had ongoing pharmacological 
treatment of their neuropathic pain. Four patients with PNeP were treated with a spinal 
cord stimulator. 
 
4.3.1 Patients with PNeP and DMA 
During the compression/ischemia-induced differential nerve block all patients with 
PNeP experienced a transition of DMA to DMD before complete loss of sensation to 
brushing in the neuropathic area. In the one-way ANOVA, there was a significant 
difference between time to transition of DMA to DMD, time to elevation of CL and 
WL, respectively, and time to loss of brushing in the control area (equal to a complete 
A-beta fibre block) during the nerve block (F (3, 51) = 23.49, p<0.001). In the post hoc 
analysis using Tukey test, transition of DMA to DMD occurred significantly prior to 
elevation of both CL (p<0.05) and WL (p<0.001) as well as before loss of sensation to 
brushing in the control area (p<0.001) (Fig. 6).  
At the time of transition of DMA to DMD 5/18 patients (nos. 1, 3, 7, 14, 17) presented 
with an elevated CL of ≥2 SD (an increase of 3.7 ˚C, 1.8 ˚C, 1.3˚C, 2.7 ˚C, 0.2 ˚C, 
respectively). One patient (no. 14) reported an elevation of the perception level to 
warmth of ≥2 SD (an increase of 5.7˚C) at the time of transition of DMA to DMD 
(Table 12).  
 
 
 
 
 
 
 32 
 
 
Fig 6. The relationship between time to transition of DMA to DMD, time to elevation 
of CL and WL and time to loss of brushing in the control area in patients with PNeP. 
Mean time to elevation and 95 % confidence intervals are presented.  
In the one-way ANOVA significant differences are indicated by p-values in the figure 
(* p<0.05, ** p<0.01, *** p<0.001).  
DMA, dynamic mechanical allodynia; DMD, dynamic mechanical dysesthesia; CL, 
perception level to cold; WL, perception level to warmth; PNeP, peripheral neuropathic 
pain.  
 
 
   33 
Table 12.  
Thermal sensory status at transition of DMA to DMD in patients with PNeP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DMA, dynamic mechanical allodynia; DMD, dynamic mechanical dysesthesia; PNeP, 
peripheral neuropathic pain; (  ), unaltered thermal perception level; (  ), elevation 
of thermal perception level; CL, perception level to cold; WL, perception level to 
warmth.   
 
 
4.3.2 Patients with CPSP and DMA 
During the compression/ischemia-induced differential nerve block only 3/7 patients 
with CPSP (nos. 22, 24, 25) experienced a transition from DMA to DMD during the 
block. The rest of the patients lost DMA without transition to DMD before complete 
loss of sensation to brushing in the neuropathic area. In the one-way ANOVA, there 
was a significant difference between time to transition/loss of DMA in the affected 
area, time to elevation of CL and WL, respectively, and time to loss of brushing in the 
control area during the nerve block (F (3, 18) = 37.81, p<0.001). In the post hoc 
analysis using Tukey test, transition/loss of DMA occurred significantly prior to 
elevation of WL (p<0.001) and before loss of sensation to brushing in the control area 
(p<0.001). No significant difference could be demonstrated between time to 
transition/loss of DMA and time to elevation of CL (p=0.99) (Fig. 7). At the time of 
transition/loss of DMA 3/7 patients (nos. 19, 20, 25) presented with an elevated CL of 
≥2 SD (an increase of 1.9 ˚C, 0.6 ˚C and 2.0 ˚C, respectively). None of the patients 
reported an elevation of the perception level to warmth at the time of transition/loss of 
DMA (Table 13).  
Patient Time to 
transition (min) 
CL at time of 
transition  
WL at time of  
transition  
1  19.0     
2  13.0   
3   7.0     
4  10.5   
5  11.0   
6   7.0   
7   3.5     
8  13.0   
9 9.5   
10 11.0   
11 5.0   
12 12.0   
13 14.0   
14 21.0       
15 14.0   
16 6.0   
17 11.0     
18 9.0   
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Fig. 7. The relationship between time to transition/loss of DMA in the affected area, 
time to elevation of CL and WL and time to loss of brushing in the control area in 
patients with CPSP. Mean time to elevation and 95 % confidence intervals are 
presented. In the one-way ANOVA significant differences are indicated by p-values in 
the figure (*** p<0.001).  
DMA, dynamic mechanical allodynia; CL, perception level to cold; WL, perception 
level to warmth; CPSP, central post stroke pain; ns, non significant. 
 
 
Table 13.  
Thermal sensory status at transition of DMA to DMD or loss of DMA in patients with 
CPSP. 
 
 
CPSP, central post stroke pain; DMA, dynamic mechanical allodynia; DMD, dynamic 
mechanical dysesthesia; CL, perception level to cold; WL, perception level to warmth; 
(  ), unaltered thermal perception level; (  ), thermal perception level elevation.  
Patient Transition 
from 
DMA to 
DMD 
Loss of 
DMA 
without 
transition 
Time to 
transition or 
loss of DMA 
(min) 
CL at time of  
transition or  
loss of DMA 
 
WL at  
time of  
transition 
 
19   Yes 12.0       
20  Yes 6.0       
21   Yes 9.5   
22 Yes  6.0   
23   Yes 8.0   
24 Yes  9.0   
25  Yes  3.0      
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4.3.3 Comparison of patients with PNeP and CPSP 
Comparing patients with PNeP (n=18) and CPSP (n=7) in the two-way ANOVA there 
was no significant difference between time to transition/loss of DMA (p=0.09), time to 
elevation of WL (p=0.53) or time to loss of sensation to brushing in the control area 
(p=0.62). However, a significant main effect of group could be demonstrated  
(F (3, 69) = 3.48, p=0.020) and time to elevation of CL during the differential nerve 
block in patients with CPSP occurred significantly prior to an elevation in patients with 
PNeP (p=0.024) (Fig. 8).  
 
 
 
 
Fig. 8. The relationship between time to transition/loss of DMA, time to elevation of 
CL and WL and time to loss of brushing in the control area in patients with PNeP 
(n=18) and in patients with CPSP (n=7) (control area in the same limb in PNeP patients 
and in the contralateral limb in CPSP patients).  
Mean time to elevation and 95 % confidence intervals are presented. In the two-way 
ANOVA significant differences are indicated by p-values in the figure (* p<0.05).  
DMA, dynamic mechanical allodynia; CL, perception level to cold; WL, perception 
level to warmth; PNeP, peripheral neuropathic pain; CPSP, central post stroke pain;  
ns = non significant. 
 36 
4.4 STUDY IV 
 
4.4.1 Perception threshold to light touch 
LTT was significantly increased on the injured side compared to the control side before 
stimulation (p<0.001) (Table 14). After SCS there was a significant decrease in LTT on 
the injured side compared to before SCS (p<0.01) (Table 15) but it was not completely 
normalized. After SCS the LTT was still significantly increased on the injured side 
compared to the uninjured side (p<0.01) (Table 16).  
 
Table 14.  
Sensory perception thresholds on the injured side compared to the uninjured 
contralateral side before SCS. 
 
Test parameter Contralateral side  Injured side  
 
p-value 
Thermal    
∆WT/ºC 4.4 [2.2 ; 9.7] 9.8 [4.0 ; 17.6] p<0.01 (2)  
∆CT/ºC 1.8 [1.3 ; 2.5] 3.2 [1.5 ; 6.8] p<0.001 (2) 
CPT/ºC 11.6 [10.0 ; 16.0] 10.0 [10.0 ; 23.2] p=0.98 (4) 
HPT/ºC 44.5 [42.5 ; 48.4] 45.1 [39.3 ; 50.0] p=0.95 (3) 
SHP 60/100 /ºC 48.3 [46.4 ; 50.0] 50.0 [42.9 ; 50.0] p=0.91 (4) 
Mechanical    
LTT/g 0.48 [0.15 ; 0.91] 2.96 [0.61 ; 8.79] p<0.001 (1)  
PPT/kPa 216 [136 ; 273] 184 [32 ; 226] p=0.18 (4) 
 
Threshold values are presented as medians with [25th and 75th percentiles].  
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal; SCS, spinal cord stimulation. 
(1) = result of one-way ANOVA, t-test 
(2) = result of one-way ANOVA, LSD-test 
(3) = result of one-way ANOVA 
(4) = result of Friedman ANOVA by ranks 
 
 
4.4.2 Pressure pain threshold 
Three patients (nos. 4, 5, 11) all reported intense pain when placing the pressure 
algometer against the skin on the injured side (i.e., mechanical allodynia) and PPT 
could therefore not be assessed. These patients were assigned a “worst-rank” value of 1 
(kPa) to allow for group level statistical analysis. Before SCS there was no significant 
difference in the PPT on the injured side compared to the contralateral side (Table 14). 
After SCS the PPT significantly increased on the injured side compared to the same 
side before SCS (p<0.01) (Table 15) but still no significant difference could be 
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demonstrated compared to the contralateral side before SCS (p=0.06) (Table 16). After 
stimulation PPT could be assessed in patients nos. 4, 5, 11, all presenting with 
mechanical allodynia before SCS.   
 
Table 15.  
Sensory perception thresholds on the injured side before and after SCS. 
 
Test parameter Injured side  
before SCS 
Injured side  
after SCS 
p-value 
Thermal    
∆WT/ºC 9.8 [4.0 ; 17.6] 8.8 [3.5 ; 12.8] p=0.28 (2) 
∆CT/ºC 3.2 [1.5 ; 6.8] 2.1 [1.7 ; 4.7] p=0.09 (2) 
CPT/ºC 10.0 [10.0 ; 23.2] 11.8 [10.0 ; 23.4] p=0.98 (4) 
HPT/ºC 45.1 [39.3 ; 50.0] 45.8 [39.3 ; 49.7] p=0.95 (3) 
SHP 60/100 /ºC 50.0 [42.9 ; 50.0] 49.4 [44.3 ; 50.0] p=0.91 (4) 
Mechanical    
LTT/g 2.96 [0.61 ; 8.79] 1.45 [0.32 ; 3.36] p<0.01 (1)  
PPT/kPa 184 [32 ; 226] 252 [168 ; 345] p<0.01 (4)  
 
Threshold values are presented as medians with [25th and 75th percentiles].  
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal; SCS, spinal cord stimulation. 
(1) = result of one-way ANOVA, t-test 
(2) = result of one-way ANOVA, LSD-test 
(3) = result of one-way ANOVA 
(4) = result of Friedman ANOVA by ranks 
 
 
4.4.3 Non-noxious thermal perception thresholds 
∆CT was significantly increased on the injured side compared to the contralateral side 
before stimulation (p<0.001) (Table 14). Following SCS there was a non significant 
decrease in ∆CT on the injured side compared to before (Table 15). However, 
comparing the injured side after SCS with the uninjured side before SCS there was a 
normalisation of ∆CT and a significant difference compared to the contralateral side 
could no longer be detected (p=0.06) (Table 16). Two patients (nos. 1, 12) lacked 
perception of warmth on the injured side reporting pain as the first sensation during 
warm stimulation. This did not change after SCS and these patients were thus excluded 
from further statistical analysis. ∆WT was significantly increased on the injured side 
(n=14) compared to the contralateral side before stimulation (p<0.001) (Table 14). SCS 
did not induce any significant alteration of ∆WT on the injured side compared to the 
same side before stimulation (Table 15). Compared to the contralateral side ∆WT was 
still significantly increased (p<0.05) after SCS (Table 16). 
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Table 16.  
Sensory perception thresholds on the injured side after SCS compared to the uninjured 
contralateral side before SCS. 
 
Test parameter Contralateral side 
before SCS 
Injured area  
after SCS 
p-value 
Thermal    
∆WT/ºC 4.4 [2.2 ; 9.7] 8.8 [3.5 ; 12.8] p<0.05 (2)  
∆CT/ºC 1.8 [1.3 ; 2.5] 2.1 [1.7 ; 4.7] p=0.06 (2) 
CPT/ºC 11.6 [10.0 ; 16.0] 11.8 [10.0 ; 23.4] p=0.98 (4) 
HPT/ºC 44.5 [42.5 ; 48.4] 45.8 [39.3 ; 49.7] p=0.95 (3) 
SHP 60/100 /ºC 48.3 [46.4 ; 50.0] 49.4 [44.3 ; 50.0] p=0.91 (4) 
Mechanical    
LTT/g 0.48 [0.15 ; 0.91] 1.45 [0.32 ; 3.36] p<0.01 (1)  
PPT/kPa 216 [136 ; 273] 252 [168 ; 345] p=0.06 (4) 
 
 
Threshold values are presented as medians with [25th and 75th percentiles].  
∆WT, perception threshold to warmth, difference from skin temperature;  
∆CT, perception threshold to cold, difference from skin temperature;  
CPT, perception threshold to cold pain; HPT, perception threshold to heat pain;  
SHP 60/100, suprathreshold heat pain rated 60/100 on NRS;  
LTT, perception threshold to light touch; PPT, pressure pain threshold;  
g, gram; ˚C, degree Celsius; kPa, kilo Pascal; SCS, spinal cord stimulation. 
(1) = result of one-way ANOVA, t-test 
(2) = result of one-way ANOVA, LSD-test 
(3) = result of one-way ANOVA 
(4) = result of Friedman ANOVA by ranks 
 
 
4.4.4 Noxious thermal stimulation 
No significant difference in CPT, HPT or sensitivity to SHP could be demonstrated 
comparing the injured side before and after SCS as well as comparing the contralateral 
side before SCS with the injured side following SCS (Table 14-16).  
 
4.4.5 The relationship between sensory thresholds and pain relief 
There was no statistically significant correlation between the degree of threshold or 
suprathreshold alteration of any parameter in the neuropathic area following SCS 
compared to before stimulation versus the degree of pain relief induced by SCS.  
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5 DISCUSSION 
 
5.1 SOMATOSENSORY FUNCTIONS AND SPONTANEOUS ONGOING 
PAIN (STUDY I) 
Patients with painful unilateral partial peripheral traumatic nerve injury demonstrated a 
significant decrease in the perception threshold to cold pain and pressure pain (i.e., 
allodynia) on the painful side in conjunction with an increase in the perception 
threshold to non-painful warmth. In patients without pain there was a significant 
perception threshold increase to light touch, cold and warmth, on the injured side but no 
difference could be demonstrated regarding painful sensory modalities. However, when 
comparing side-to-side differences of sensory functions between groups of patients 
with and without pain no significant differences were found. This calls for cautious 
interpretation of our data.  
 
Previous studies on peripheral traumatic nerve injury (Gottrup et al., 2000; Aasvang et 
al., 2008) included patients with possible confounding factors regarding the aetiology 
of pain. In this, we believe, comparatively homogenous patient group there were no 
obvious signs of neurogenic inflammation (Torebjork et al., 1992; Koltzenburg et al., 
1994; Rowbotham and Fields, 1996) as an indication of possible peripheral 
sensitization. We can not rule out, however, the presence of facilitated transducer 
mechanisms to certain stimulus energies in groups of nociceptors. 
 
Some sensory deficit is an anticipated sequel from loss of fibres as a result of nerve 
injury and a common feature of neuropathic pain conditions. In experimental models of 
traumatic peripheral nerve injuries axotomy not only causes deafferentation peripheral 
to the site of injury but also induces substantial retrograde transganglionic degeneration 
into the spinal cord of cutaneous sensory dorsal root ganglion (DRG) neurons (Ygge 
and Aldskogius, 1984; Hu and McLachlan, 2003), and hence loss of spinal cord input. 
Immediate nerve repair has been found not to completely prevent this neuronal 
degeneration but can to some extent increase the survival of sensory neurones (Welin et 
al., 2008). However, motor neurone loss can be almost totally eliminated and function 
restored by an early nerve repair (Ma et al., 2003). In the pain-free group in this study 
all patients had undergone nerve suturing and demonstrated sensory loss in more non-
painful domains than patients with pain. This could indicate that nerve suturing may 
prevent increased excitability and the development of pain. 
 
Results regarding sensory deficits from studies in patients with painful polyneuropathy 
are at variance with our current findings. In patients with HIV neuropathy Martin and 
co-workers reported a more pronounced impairment of C-fibre mediated innocuous 
warm perception thresholds in patients with pain than in pain-free patients (Martin et 
al., 2003). Patients with painful diabetic neuropathy demonstrated a significantly more 
pronounced impairment of non nociceptive thermal and vibration detection thresholds 
compared to patients without pain (Ziegler et al., 1988) suggesting a more pronounced 
loss of both small and large diameter fibres in patients with pain. However, Bouhassira 
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and co-workers found no significant difference between any of the thermal parameters 
in patients with and without pain after HIV neuropathy (Bouhassira et al., 1999).  
 
Although not amounting to significant side-to-side differences between groups the 
disparate result on somatosensory functions in patients with and without pain could be 
signs of different inherent pain protective mechanisms in the two groups. The increase 
in excitability in nociceptive channels reflected by heat- and pressure allodynia in 
patients with pain may indicate a loss of pain regulatory mechanisms, although the 
level of such pathophysiology along the neuraxis is unknown and may have a bearing 
on not only stimulus-evoked pain but also the presence of spontaneous pain. 
Augmented stimulus-evoked pain has been reported by others from studies on painful 
neuropathy. In patients with post-mastectomy pain (Gottrup et al., 2000) and pain after 
unilateral inguinal herniotomy (Aasvang et al., 2008), allodynia to pressure and 
abnormal temporal summation to pinprick pain on the injured side compared to the 
normal side have been demonstrated, suggesting peripheral and/or central 
hyperexcitability contributing to, at least, stimulus-evoked pain. Decreased mechanical 
pain thresholds and increased responses to suprathreshold nociceptive mechanical 
stimulation were demonstrated also in patients with painful polyneuropathy due to HIV 
infection (Bouhassira et al., 1999).  
 
Besides increased peripheral activity due to, e.g., ectopic impulse discharge and 
ephaptic transmission increase in spinal cord excitability has been suggested to be a 
built in compensation for some of the deficits in the afferent nociceptive drive after 
nerve injury (Chapman et al., 1998; Suzuki and Dickenson, 2000; Suzuki et al., 2000). 
Also, disinhibition of spinal neurons due to loss of peripheral input may come into play 
(Castro-Lopes et al., 1993; Moore et al., 2002). Increased spinal excitability induced by 
a peripheral nerve injury may thus compensate (or over-compensate) for or restore 
spinal responses to peripheral stimuli in spite of decreased afferent input. Variation in 
the degree of peripheral spontaneous activity, compensation or disinhibition anywhere 
along the neuraxis could provide an explanation to the development of spontaneous- 
and stimulus-evoked pain and also to the diverse somatosensory findings seen in 
patients with and without pain after peripheral nerve injury (Lindblom and Tegner, 
1985; Hansson and Kinnman, 1996; Pertovaara, 1998). In this study, patients without 
pain presented with increased perception thresholds only to non-painful stimuli (i.e., 
hypoesthesia to light touch, warmth and cold) on the injured side compared to the non-
injured side and would thus be devoid of protruding over-compensation mechanisms as 
part of a normal protective system against pain development after traumatic peripheral 
nerve injury. 
 
Suprathreshold magnitude estimation of heat pain stimuli were included (Hansson and 
Lindblom, 1992; Vestergaard et al., 1995; Attal et al., 1999; Bouhassira et al., 1999) in 
order to challenge a perhaps more relevant part of the stimulus-response function of 
this pain channel. In the present study suprathreshold heat pain stimuli elicited similar 
responses in both patients with and without pain and no significant side-to-side 
difference was found. The lack of a detectable difference in heat pain threshold and 
magnitude estimation of suprathreshold heat pain may be explained by the relatively 
lesser need for spatial summation in the periphery with regard to this modality 
(Yarnitsky and Ochoa, 1991). This relatively independence on spatial summation may 
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be of phylogenetic importance since the sensation of heat pain is an important part of 
body protection to external energies. A detectable difference in function of this C-
nociceptor channel due to loss of fibres subserving this sense therefore has to be 
substantial in order to be detectable.  
 
5.2 SOMATOSENSORY FUNCTIONS AND MECHANICAL ALLODYNIA 
(STUDY II, III) 
It is widely accepted that during a compression/ischemia induced nerve block 
conduction in myelinated fibres is blocked successively depending on thickness and 
starting at an early phase prior to unmyelinated fibres (Gasser and Erlanger, 1929; 
Sinclair and Hinshaw, 1950; Torebjork and Hallin, 1973). It has been claimed, although 
not observed in thesis work, that the sequence of blocking within the myelinated fibre 
group is insufficiently differentiated by such an approach as shown by the nearly 
simultaneous disappearance of the sensation of light touch (A-beta) and cold (A-delta) 
(Yarnitsky and Ochoa, 1989; Yarnitsky and Ochoa, 1991). 
 
5.2.1 Dynamic and static mechanical allodynia (Study II) 
Elevation of both vF1 in patients with DMA and vF10 in patients with SMA occurred 
concurrently in time and significantly prior to an increase in the perception level to cold 
during the continuous nerve block, pointing to the involvement of A-beta fibres as the 
peripheral substrate. Single patients demonstrated a slight decrease in cold perception 
levels at the time of elevation of vF1 or vF10 and a possible contribution to mechanical 
allodynia from A-delta-fibres can therefore not completely be ruled out although the 
recorded alterations were minor. None of the patients reported an elevation of the 
perception level to warmth at the time of elevation of vF1 or vF10 excluding 
contribution from C-fibres.  
 
Further, only patients with clinically established SMA (n=9) reported continuous pain 
to a sustained 10 s von Frey filament stimulation (vF10). Patients with only DMA 
(n=9) reported pain merely for the initial 1 – 3 s of the total stimulus duration of 10 s 
and for a few seconds after the filament was lifted from the skin. In the study by Ochoa 
and Yarnitsky SMA in patients with neuropathic pain persisted in a majority (15/18) of 
patients during a compression/ischemia nerve block although diminished in intensity 
(in 10/15 patients) when loss of cold and touch sensation was established and warm 
sensation remained unaltered (Ochoa and Yarnitsky, 1993). The result was interpreted 
by the authors as an indication that SMA predominantly was mediated by C-fibres 
(Ochoa and Yarnitsky, 1993).  
 
Regarding the possible involvement of A-delta fibres in mediating SMA in the present 
study we monitored cold-activated A-delta fibres during the block but did not explicitly 
test the function of A-fibre nociceptors, i.e., first pain to heat, mechanical or electrical 
stimuli. Since A-fibre nociceptors have been shown to be more resistant to a 
compression/ischemia nerve block than all other A-fibres some of their axons may still 
conduct after all tested A-fibre related functions (i.e., touch and cold) are blocked 
(Ziegler et al., 1999). However, A-fibre nociceptors seem not to be the main candidate 
as the peripheral substrate of SMA because the elevation of vF1 and vF10 occurred 
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early during the block when A-fibre nociceptors would be fairly resistant to 
compression/ischemia. This supports the role of A-beta fibres as peripheral mediators 
to both vF1 and vF10 in the von Frey stimulus range used in this study although 
different receptor organs may be involved, i.e., rapidly (RA) and slowly (SA-I) 
adapting mechanoreceptors, respectively.  
 
The finding of A-beta fibre involvement in DMA lends support from previous 
experiments on patients with peripheral neuropathic pain indicating a crucial role for 
low threshold A-beta fibres in the generation of pain during light mechanical stimuli 
(Lindblom and Verrillo, 1979; Campbell et al., 1988; Price et al., 1989; Nurmikko et 
al., 1991; Ochoa and Yarnitsky, 1993). Other myelinated afferents than low threshold 
A-beta mechanoreceptive fibres may, however be implicated in DMA in patients with 
PNeP such as nociceptive A-beta fibres (Cain et al., 2001; Djouhri and Lawson, 2004) 
and A-delta low-threshold mechanoreceptors (Adriaensen et al., 1983). The 
involvement of C-fibre nociceptors with low mechanical threshold (Slugg et al., 2000) 
and low-threshold mechanoreceptive C-fibres (Vallbo et al., 1993; McGlone et al., 
2007) seem less conceivable since C-fibres were unaffected during the continuous 
nerve block as judged by the preservation of warm perception at detection level.  
 
Techniques to assess different allodynias at perception threshold level are in demand as 
adjuncts to suprathreshold stimuli in intervention studies aimed at modifying these 
stimulus-evoked phenomena (Samuelsson et al., 2005). Pain induced by usually non-
painful von Frey filament prodding of the skin has been reported on in patients with 
neuropathic pain and may be a useful approach if the type of stimulation could be 
linked to activation of specific peripheral nerve fibres (Lindblom and Hansson, 1991).  
 
5.2.2 Dynamic mechanical allodynia and dysesthesia (Study III) 
There was a transition of DMA to DMD during the compression/ischemia-induced 
nerve block in all patients with PNeP (n=18) and in 3/7 patients with CPSP. The 
remaining patients with CPSP lost DMA without transition to DMD. The transition of 
DMA to DMD or loss of DMA (in patients without transition) occurred early and 
concurrently in time during the nerve block and was paralleled by a continuous 
impairment of mainly A-beta fibre function suggesting DMA to be mediated via that 
group of fibres in both groups of patients. Single patients in both groups demonstrated a 
slight decrease in cold perception levels at the time of transition/loss of DMA and a 
possible contribution to DMA from A-delta fibres can therefore not completely be 
ruled out, although the recorded alterations were minor. Only one patient with PNeP 
and none of the patients with CPSP reported an elevation of the perception level to 
warmth at the time of transition/loss of DMA excluding a major contribution from C-
fibres.  
 
In patients with PNeP the transition from DMA to DMD occurred significantly prior to 
an increase in the perception level to cold but no significant difference between time to 
transition/loss of DMA and time to increase in the perception level of cold could be 
demonstrated in patients with CPSP. In patients with CPSP the control area used to 
monitor progression of the nerve block was located in the contralateral non-painful 
limb and it is conceivable that disturbances in attention induced by sensations 
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(paresthesias, pain) from the effect of the sphygmomanometer cuff could explain the 
early but small increase in the perception level to cold seen in 3/7 patients with CPSP 
already during the initial phase of the nerve block. This initial increase was not seen in 
patients with PNeP indicating that possible distraction from cuff related effects were 
minor in this group of patients where the nerve block was performed in an already 
painful limb. In patients with CPSP the lack of statistical significance on a group level 
between time to transition/loss of DMA and time to increase in the perception level of 
cold could also indicate a type II error since the study was performed in a 
comparatively small group of CPSP patients due to difficulties in recruiting patients 
fulfilling preset inclusion criteria. 
   
The fact that the transition of DMA to DMD during the nerve block occurred when 
mainly only A-beta fibre function was affected indicates that also DMD has a 
peripheral substrate within the A-beta group. We therefore suggest DMA to be the 
hyperbole of DMD, the difference being the number of mechanoreceptive fibres having 
access to the nociceptive system in the periphery via ephaptic transmission or in the 
central nervous system. 
 
5.3 SOMATOSENSORY FUNCTIONS AND PAIN RELIEF (STUDY IV) 
Following SCS there was a significant decrease in the perception threshold to light 
touch and a significant increase in the pressure pain threshold in the neuropathic area 
compared to before SCS. Compared to the contralateral side these perception 
thresholds changed towards normalisation also including a significant normalisation of 
the perception threshold to non painful cold. SCS did not induce any significant 
alterations in sensitivity to noxious temperature stimulation. In addition, there was no 
significant correlation between the degree of threshold alterations of any mechanical- 
or thermal parameter versus the degree of pain relief induced by SCS.  
  
Besides increased peripheral activity due to, e.g., ectopic impulse discharge and 
ephaptic transmission experimental animal models suggest a possible increase in spinal 
excitability following a peripheral nerve injury that might partially compensate (or 
over-compensate) for or even restore spinal responses to peripheral stimuli in spite of 
decreased afferent input (Chapman et al., 1998; Suzuki and Dickenson, 2000; Suzuki et 
al., 2000). This may provide an explanation as to the development of spontaneous- and 
stimulus-evoked pain and also to the diverse somatosensory findings seen in patients 
(Hansson and Kinnman, 1996). In the present study sensitivity to innocuous mechanical 
and thermal stimuli was significantly decreased on the injured side compared to the 
uninjured side before SCS but no difference could be demonstrated regarding painful 
mechanical or thermal stimulation. This is at variance with previous reports of 
increased mechanical and/or thermal pain sensitivity on the injured side in patients with 
post-mastectomy pain (Gottrup et al., 2000), pain after unilateral inguinal herniotomy 
(Aasvang et al., 2008) and pain after a variety of peripheral nerve injuries (Landerholm 
et al., 2010) (Study I). The contrasting results could in fact indicate that long term use 
of SCS may induce reversible or permanent changes in spinal excitability. This notion 
is supported by a study on patients with post amputation pain reporting decreased 
sensitivity to noxious and innocuous electrical stimulation after long-term use of SCS 
not seen in short-term stimulation during a test period (Doerr et al., 1978).  
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We found increased sensitivity to light touch and non-painful cold in conjunction with 
decreased sensitivity to pressure pain on the injured side following SCS induced pain 
relief. This is in accordance with previous reports of improved sensitivity of 
somatosensory function as a result of pain relief indicating a possible link to the release 
of a proposed functional block by a given pain relieving measure on somatosensory 
function induced by activity in the nociceptive system (Lindblom and Verrillo, 1979; 
Marchettini et al., 1992). The underlying mechanisms of such a functional block are not 
known. In addition, in the present study SCS did not induce any significant alterations 
of sensitivity to noxious thermal stimulation in the painful area which is consistent with 
findings from Eisenberg and co-workers (Eisenberg et al., 2006).  
  
The lack of a significant correlation between the degree of sensory threshold changes 
and the degree of pain relief induced by SCS indicates that the observed sensory 
changes following SCS are mechanistically unrelated to pain relief. The previously 
reported positive correlation between decreased sensitivity to noxious thermal 
stimulation and pain relief following SCS demonstrated in patients with post surgical 
pain should be cautiously interpreted since the sensory testing was made in an area 
influenced by SCS-induced paresthesia but was located outside the painful area 
(Marchand et al., 1991). Hence, the outcome of that study cannot be compared to our 
results where sensory assessments were made within the painful area.  
 
5.4 METHODOLOGICAL SHORTCOMINGS 
5.4.1 Study I 
There are obviously several possible explanations as to why no significant difference in 
any single parameter comparing side-to-side differences between groups was found in 
this study and certain shortcomings need consideration. The two groups differ with 
regard to the cause of nerve injury where all patients without pain had a clear partial cut 
injury as judged by visual inspection during surgery, and were sutured, while patients 
in the pain group are more heterogeneous. We can not rule out that this diversity could 
contribute to the non-significant differences in single parameters between groups. The 
optimal situation would be to compare patients with partial injuries with and without 
pain where all nerves were sutured or non-sutured. It deserves to be mentioned that 
there is no available information from human clinical studies about which nerves, pure 
sensory or mixed, that are more prone after injury to be the source of neuropathic pain. 
The fact that approximately half of the patients in the pain group had injuries to pure 
sensory nerves and the other half injuries to mixed nerves may indicate that 
development of neuropathic pain is not depending on the proportion of sensory nerve 
fibres in the injured nerve. None of the patients participating in this study had 
undergone neurophysiological examination as part of clinical routine work-up. 
Therefore, in the pain group the diagnosis of neuropathic pain can not be assessed with 
the highest degree of certainty, i.e., ‘definite’ neuropathic pain, according to the 
recently proposed grading system (Treede et al., 2008). Hence, we only claim that 
‘probable’ neuropathic pain was at hand. A type II error must be considered since the 
study was performed in a comparatively small group of patients. A post-hoc power 
analysis revealed the need for increasing the sample size to several hundred patients to 
be able to demonstrate a possible difference in any parameter between groups. In 
support of this, the relatively large variability in pain thresholds found in healthy 
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subjects (Rolke et al., 2006) is a relevant observation. Such a study would be extremely 
time consuming and calls for the need of a multicenter design. We lack appropriate 
reference values for the employed QST tests in the multiple body regions that were 
examined. This would require a huge reference value data base from healthy subjects 
and is not available in our laboratory or in the literature. Moreover, comparing sensory 
function in the injured area with the contralateral homologous site in the individual 
patient is not possible since the minimum difference to be regarded as pathological is 
unknown. Based on this, no conclusions can be drawn on an individual level. Also, the 
distribution of sensory abnormalities within the innervation territory of the injured 
nerve might not be homogeneous and the assessments made in a restricted part of the 
neuropathic area may randomly pick up function not representative of the larger part of 
that area (Leffler and Hansson, 2008). In addition, if the pain generator is located in a 
neuroma proximal to the examination area the spontaneous activity is not likely to be 
reflected by the somatosensory profile within that area. Finally, and perhaps most 
importantly, altered sensory perception thresholds, especially non-nociceptive 
modalities, may not at all be related to pathophysiological mechanisms involved in 
spontaneous ongoing neuropathic pain after peripheral nerve injury. 
 
5.4.2 Study II 
Some methodological considerations deserve attention. The von Frey filaments used in 
this study did not evoke pain in the contralateral pain-free area or in the control area in 
any patient. However, activation of nociceptive somatosensory channels cannot be 
ruled out because numerous human and animal studies have shown that the used range 
of von Frey filaments is sufficient to activate both unmyelinated and myelinated 
nociceptors, however not necessarily giving rise to pain (Adriaensen et al., 1983; 
Schmidt et al., 1995; Andrew and Greenspan, 1999; Slugg et al., 2000). In addition, the 
used range of von Frey filaments increased logarithmically thereby providing a less 
detailed resolution of measurements in the higher stimulus range, i.e., up to 30 g. Also, 
the examination of different sensory modalities was made cyclically and approximately 
every 1 – 3 min during the nerve block. This range was allowed to secure cessation of 
stimulus-induced aftersensations in some patients and thus there is a possibility of 
perception level elevations occurring between examination intervals hence resulting in 
a recorded value of the time to perception level elevation higher than the true value. 
Furthermore, an increased perception level early on during the nerve block could be 
related to disturbances in attention induced by sensations (paresthesias, pain) from the 
effect of the sphygmomanometer cuff. However, in this study there was no initial 
increase of temperature perception levels during the first 5 minutes of the block 
indicating that distraction from cuff related effects were minor at least in the non-
neuropathic skin area.  
 
5.4.3 Study III 
Some methodological issues should be considered. In patients with CPSP there is a 
possibility of biased patient selection criteria since all patients with pain in the upper 
limb (n=6) had to have spared motor function in the painful hand to be able to 
participate in the study. Hence all patients with CPSP had primarily sensory symptoms 
as a sequel of their lesion. Also, the examination of different sensory modalities was 
made cyclically and approximately every 1 – 3 min during the nerve block. This range 
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was allowed to secure cessation of stimulus-induced aftersensations in some patients 
and thus there is a possibility of perception level elevations occurring between 
examination intervals. Hence in patients with CPSP a possible transition from DMA to 
DMD and subsequent loss of DMD could have been missed in 4/7 patients. In patients 
with PNeP the recorded time to increase of CL could be higher than the true value 
resulting in a false significant difference between the time to transition of DMA to 
DMD and time to increase of CL. This possibility, however, seems less conceivable 
since only a few patients reported an increase of CL occurring close in time to 
transition of DMA to DMD.   
 
5.4.4 Study IV 
Some methodological considerations deserve attention. Since the primary aim of this 
study was to investigate the modulatory effect of SCS on somatosensory functions 
within the area of neuropathy and its correlation to relief of spontaneous pain 
examination of a control group consisting of patients reporting no pain relief by SCS 
was excluded. This strategy was also supported by the fact that long-term SCS may 
induce changes in spinal excitability possibly affecting the outcome of sensory testing 
(Doerr et al., 1978) not seen in short-term stimulation during a test period prior to 
permanent implantation of the SCS device. Also, in our setting patients with painful 
neuropathy and radiculopathy that fail to respond to SCS during the test period will not 
be eligible for permanent implant. Hence, a comparable control group is not available. 
In addition, the distribution of sensory abnormalities within the innervation territory of 
the injured nervous structure might not be homogeneous and assessments made in a 
restricted part of the neuropathic area may just randomly pick up function not 
representative of the larger part of that area (Leffler and Hansson, 2008). Further, to 
allow for group level statistical analysis several patients were assigned cut-off values or 
‘worst-rank values’ for the tested parameters if they failed to respond during the 
examination. This could explain why no significant difference in any of the noxious 
thermal parameters was found comparing the injured side before and after SCS as well 
as the contralateral side before SCS and the injured side after stimulation since 
assignment of ‘worst-rank values’ were especially frequent when testing these 
parameters.  
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6 THESIS SUMMARY 
 
6.1 STUDY I 
In conclusion, increased pain sensitivity to cold and pressure was found on the injured 
side in pain patients, pointing to hyperexcitability in the pain system, a finding not 
verified by a more challenging analysis of side-to-side differences between patients 
with and without pain. To what extent the indications of hyperexcitability in the pain 
system contribute to spontaneous pain as a result of increased peripheral activity, 
disinhibition or facilitatory (over) compensation mechanisms, or combinations thereof, 
cannot be determined. Pain-free patients may possess an inherent resistance to respond 
with such alterations to loss of peripheral input thereby protecting them from pain 
development after nerve injury. Since only a fraction of patients with peripheral nerve 
injuries suffer from pain inborn pain protective mechanisms seems to be the normal 
condition in most individuals and the malfunction in these systems resulting in 
neuropathic pain after injury to be an exception.  
 
6.2 STUDY II 
In conclusion, it is proposed that pain induced by 1 s and 10 s von Frey filament 
stimulation at perception threshold in patients with neuropathy and DMA/SMA is 
predominantly mediated by activity in peripheral non-nociceptive A-beta mechano-
receptors although different receptor organs may be involved, i.e., rapidly (RA) and 
slowly (SA-I) adapting mechanoreceptors, in DMA and SMA, respectively. The 
methods used to assess the perception thresholds of mechanical allodynias deserve 
further attention as possible adjuncts to suprathreshold stimuli in intervention studies 
aimed at modifying these stimulus-evoked phenomena.  
 
6.3 STUDY III 
In conclusion, DMA in patients with neuropathic pain is transferred to a dysesthetic 
sensation or lost without transition paralleled by a continuous impairment of mainly A-
beta-fibre function during a compression/ischemia-induced differential nerve block. 
These findings point to DMA and DMD both being mediated via that group of fibres 
both in patients with PNeP and CPSP. Hence, dynamic mechanical allodynia is the 
hyperbole of dynamic mechanical dysesthesia despite the location of the lesion level 
along the neuroaxis the difference being the number of mechanoreceptive fibres having 
access to the nociceptive system. 
 
6.4 STUDY IV 
In conclusion, decreased perception threshold to light touch and increased perception 
threshold to pressure pain were found in the neuropathic area following SCS compared 
to before stimulation. Compared to the contralateral side these perception thresholds 
changed towards normalisation also including a significant normalisation of the 
perception threshold to non painful cold. These alterations indicate a possible link to 
the release of a functional block on somatosensory function induced by activity in the 
nociceptive system. The degree of the observed sensory changes following SCS was 
however unrelated to the degree of pain relief in the studied patient group. 
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8 SAMMANFATTNING PÅ SVENSKA 
 
Bakgrund och syfte: Patienter med neuropatisk smärta lider av spontansmärta och 
ibland även av stimulusutlöst smärta. Allodyni definieras som smärta utlöst av en 
normalt icke smärtsam stimulering. Dynamisk mekanisk allodyni är smärta utlöst av en 
lätt strykning över hudytan och statisk mekanisk allodyni framkallas av ett ihållande 
lätt tryck mot huden. Undergrupper av patienter rapporterar att dynamisk mekanisk 
allodyni kan variera i intensitet över tid och ibland endast upplevas som obehag 
(dysestesi). Avhandlingsarbetets syfte var att söka efter gemensamma nämnare för 
somatosensorisk funktion i det nervskadade området som kan kopplas till 
bakomliggande mekanismer för utveckling av eller skydd mot smärta efter traumatisk 
perifer nervskada (Studie I). Därutöver var avsikten att undersöka om kort eller längre 
icke smärtsamt tryck med von Frey filament mot huden i det nervskadade området kan 
användas för att mäta perceptionströsklar för dynamisk mekanisk och statisk mekanisk 
allodyni (Studie II). Dessutom var syftet att undersöka om dynamisk mekanisk allodyni 
är en förstärkning av dynamisk mekanisk dysestesi båda medierade av nervfibrer som i 
periferin förmedlar beröring (Studie III). Slutligen ville vi även studera den 
modulerande effekten av ryggmärsstimulering på somatosensorisk funktion inom det 
smärtande området hos patienter med perifer neuropatisk smärta (Studie IV).   
 
Metod: Med metoder för kvantitativ känseltestning gjordes en detaljerad analys av den 
somatosensoriska funktionen hos patienter med och utan smärta efter ensidig perifer 
traumatisk nervskada (Studie I) samt hos patienter med en långvarig smärtlindrande 
effekt på minst 30 % efter ryggmärgsstimulering (Studie IV). Kombinationen av en 
differentierad nervblockad och upprepad kvantitativ känseltestning användes för att 
fastställa vilken typ av nervfibrer som bidrar till smärta utlöst av 1 s respektive 10 s 
stimulering av huden med von Frey filament (Studie II). Samma metodik användes för 
att kartlägga vilka perifera fibrer som är substratet för dynamisk mekanisk allodyni och 
dysestesi (Studie III). 
 
Resultat: Patienter med smärta uppvisade allodyni för kyla och tryck tillsammans med 
en ökad perceptionströskel för icke smärtsam värme på den skadade sidan jämfört med 
kontrollsidan. Patienter utan smärta hade ökade perceptionströsklar för lätt beröring, 
kyla och värme på den skadade sidan. Ingen signifikant skillnad kunde påvisas vid 
jämförelser av sidoskillnader mellan patienter med och utan smärta. Under 
nervblockaden sågs en minskad känslighet för smärta utlöst av både 1 s respektive 10 s 
stimulering av huden med von Frey filament. Denna förändring inträffade samtidigt för 
både kort och längre stimuleringstid och signifikant före en ökning av 
perceptionströsklarna för både kyla och värme. Under nervblockaden sågs även en 
övergång från dynamisk mekanisk allodyni till dynamisk mekanisk dysestesi hos alla 
patienter med perifer neuropatisk smärta och hos 3/7 patienter med central smärta efter 
en stroke. Övriga patienter förlorade sin dynamiska mekaniska allodyni utan övergång 
till dysestesi. Både övergång och förlust av dynamisk mekanisk allodyni inträffade 
tidigt under nervblockaden när i huvudsak endast nervfibrer som förmedlar beröring 
var påverkade. Efter ryggmärgsstimulering påvisades en sänkt perceptionströskel för 
lätt beröring och en ökad perceptionströskel för trycksmärta i det neuropatiska området 
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jämfört med före stimulering. Jämfört med den motsatta sidan förändrades dessa 
perceptionströsklar mot normalisering och inkluderande även en signifikant 
normalisering av perceptionströskeln för kyla. Ryggmärgsstimulering förändrade inte 
känsligheten för smärtsam temperaturstimulering. Ingen signifikant korrelation kunde 
påvisas mellan grad av tröskelförändring och grad av smärtlindring. 
 
Slutsatser: Fyndet av ökad smärtkänslighet för kyla och tryck på den skadade sidan 
hos patienter med smärta efter traumatisk perifer nervskada talar för överretbarhet i 
smärtsystemet, vilket dock inte kunde bekräftas av en mer utmanande statistisk analys 
av sidoskillnader mellan patienter med och utan smärta. Nervfibrer som normalt 
förmedlar beröring är det perifera underlaget för smärta utlöst av både 1 s respektive 10 
s stimulering av huden med von Frey filament. Dock kan olika receptororgan vara 
involverade d.v.s. snabbt adapterande respektive långsamt adapterande 
mekanoreceptorer. Övergången från allodyni till dysestesi och bortfallet av dynamisk 
mekanisk allodyni utan övergång uppstod tidigt och samtidigt under en differentierad 
nervblockad parallellt med en kontinuerlig försämring av funktionen hos i huvudsak de 
nervfibrer som förmedlar beröring. Vi föreslår därför att dynamisk mekanisk allodyni 
är en förstärkning av dynamisk mekanisk dysestesi där skillnaden i upplevelse beror på 
antalet mekanoreceptiva fibrer som har kontakt med smärtsystemet. Förändrad 
sensorisk funktion efter ryggmärgsstimulering indikerar en koppling till bortfall av en 
funktionell blockering av somatosensorisk funktion framkallad av aktivitet i 
smärtsystemet. Ingen signifikant korrelation kunde påvisas mellan grad av 
tröskelförändring och grad av smärtlindring efter ryggmärgsstimulering. 
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